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ABSTRACT 
Drug addiction is an intractable psychiatric disorder exerting deleterious impact on public health 
in the United States and beyond. While the neurobiology of addiction has become clearer over 
the last few decades, addiction therapies remain largely ineffective. Given recent evidence that a 
gut-brain axis might influence neuropsychiatric disorders, we explored possible links between 
gut bacteria and cocaine-related behavior. We hypothesized that gut microbial communities and 
cocaine intake are linked in such way that microbiota profiles can predict susceptibility to drug 
use and that drug use alters microbiota composition to enhance drug reward, hence resulting in a 
vicious cycle of drug use and abuse. Furthermore, although adolescence is a developmental stage 
associated with high rates of experimentation with drugs of abuse, adolescence is also a period 
associated with resilience to aversive stimuli. Thus, we predicted that adolescents would be 
protected from this vicious cycle. Adolescent and adult male Wistar rats were tested in the 
intravenous cocaine self-administration model, while their fecal samples were analyzed for 
bacterial abundance (qPCR) and microbiota profiles (NextGen Sequencing of 16S rRNA). With 
adult rats, experimentation revealed distinct microbiota profiles among low vs. high responders 
to cocaine reward and reinforcement, especially after long-access cocaine self-administration. 
Moreover, the relative abundance of two specific microbial groups at baseline predicted low vs. 
high addiction vulnerability, perhaps warranting investigation as biomarkers of addiction. After 
establishing a new white noise training procedure and confirming adolescent resistance to an 
aversive white noise stimulus, we also manipulated the microbiota to reveal that antibiotic-
induced gut microbial depletion increased cue-induced reinstatement of cocaine-seeking after 
abstinence in a model of drug relapse. Yet this effect was observed only in adult rats, not 
adolescent-onset groups. Treatment with a probiotic formulation during abstinence rescued 
normal levels of reinstatement in adult rats, suggesting that probiotics may be effective 
adjunctive therapies for addiction. Overall, this body of work provides another example of 
adolescent resilience to the enduring effects of physiological perturbations. This work also 
supports an important role for the gut-brain axis in drug reward and reinforcement, ultimately 
suggesting new treatment approaches for addiction. 
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1 INTRODUCTION  
1.1 Overview  
Substance use disorder (SUD), a condition in which chronic substance use leads to mental, 
physical, and behavioral deficits (American Psychiatric Association: 2013) affects more than 25 
million Americans per month (NSDUH, et al. 2013). With regard to cocaine, treatments to 
prevent continued use and attenuate relapse are ineffective (Fischer et al., 2015; Simpson et al., 
1999). The main reason treatments are ineffective is that addiction is associated with long-lasting 
vulnerability to relapse, even after long periods of abstinence (Cregler et al. 1986). 
Recent evidence suggests that microbes in the gut are associated with several 
neuropsychiatric disorders (Cryan et al. 2019), including substance use disorder (Mekel et al. 
2019). We hypothesized that microbiota composition and drug use are linked in such a way that 
microbiota profiles can predict susceptibility to drug use, and that drug use alters microbiota 
composition, hence resulting in a vicious cycle of drug use and abuse.  
Furthermore, adolescence is the developmental stage when drug use is often first initiated 
among individuals who identify as addicted later in life (Kandel et al. 1978; Kandel et al. 1984). 
Adolescence is a period of rapid development, during which hormone levels, CNS circuitry, and 
behaviors are still maturing (Spear et al. 2000; Spear et al. 2010). The gut microbiota is also 
shown to be distinct in adolescents compared to adults and susceptible to change (Agans et al. 
2011). Based on adolescent resilience to aversive stimuli and some enduring drug effects, we 
hypothesized that adolescents are protected from the bidirectional impact between the gut 
microbiome and drug reward and reinforcement.   
 
2 
1.2 Behavioral testing: The Self-Administration and Reinstatement Model 
Animal models are used frequently to study the effects of drug abuse, given ethical issues 
with drug testing in humans. The self-administration and reinstatement model has been the gold 
standard to study the reinforcing qualities of pharmacological compounds for 50 years. The 
model has face validity and predictive validity for substance abuse disorder (O’Conner et al. 
2011). Based on classic work by Edward Thorndike (Thorndike et al. 1905), B.F. Skinner 
(Skinner et al. 1953), James Olds, and Peter Milner, self-administration and reinstatement tests 
are conducted in customized Skinner boxes (operant conditioning chambers). The equipment is 
used to test whether presentation of a stimulus reinforces (or punishes) a behavior such as lever-
pressing. In such chambers, we assess the extent to which a test subject finds intravenous 
infusions of cocaine to be reinforcing under a variety of conditions. Experimental manipulation 
of environmental cues in the operant conditioning chambers can reveal additional associations 
between reinforcing stimuli (e.g. drug infusions) and auditory or visual stimuli (e.g. white noise 
or cue lights), and we used such cocaine-associated cues in a model of relapse, known as cue-
induced reinstatement of drug-seeking after abstinence.  
Compulsive drug use despite adverse consequences is a symptom of substance use disorder, 
and previous studies confirm that rodents compulsively seek drugs similar to humans (Koob et 
al. 2001). Recently, self-administration models have included negative consequences associated 
with drug infusions (Barnea-Ygael et al. 2012; Katzir et al. 2007; Holtz et al. 2015) These 
“punished” models of cocaine self-administration may be considered more translatable to the 
human condition of addiction than self-administration parameters that do not include such 
adverse consequences of drug intake. Most humans experience negative consequences in the 
throes of addiction, such as loss of employment, alienation from friends and family, and 
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depression or anxiety (Lander et al. 2013). Therefore, one goal of this dissertation was to validate 
white noise as a method of modeling the aversive nature of substance abuse. This goal emerged 
after we investigated whether the removal of white noise could be used as a method to facilitate 
acquisition of lever pressing in operant conditioning chambers. Many different procedures are 
used for facilitating acquisition behavior, including priming injections of the drug, food 
restriction and food self-administration, oral tastants on the manipulandum, autoshaping, and 
fading (Caroll et al. 2011). Each of these procedures has pros and cons, some of which are 
difficult to overcome when testing different age groups. For example, differential effects of food 
deprivation across age groups may alter acquisition of lever-pressing through food self-
administration. On the other hand, white noise is an alternative that is not consumable and non-
invasive. We will show validation of this white noise in the self-administration model later in 
this dissertation and its use for facilitating acquisition of lever pressing will be used in 
subsequent behavioral experiments to address behavioral questions asked in this dissertation.  
1.3 Experimental Subjects: Wistar rats (Rattus norvegicus) 
In an attempt to answer questions about human behavior and disease, animal models have 
been used since the days of ancient Greeks (Ericsson et al. 2013). The research subjects in this 
dissertation are Wistar rats (Rattus norvegicus), a strain of albino rats that have been used in 
scientific research since the early 1900s (Hatai et al. 1907). Their mainstay in scientific research 
seems to originate in their propensity for extraordinary memory compared to other rodent models 
(Watson et al. 1903). Due to similar physiology compared with other mammals, including 
humans, they often have similar disease phenotypes and sequelae, and they are the most studied 
animal model (Aitman et al. 2016). While the use of rats as an animal model has been 
challenged, rats in drug self-administration experiments provide high face and predictive validity 
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for studies on drug addiction (O’Connor et al. 2011;Panillo et al. 2007; Fuchs et al. 2007; 
Epstein et al. 2003; Shaham et al. 2003).  
1.4 The Reward System 
External stimuli and internal states that benefit an animal or species generally elicit 
approach behaviors and are known as rewards. When their presentation reinforces behavioral 
sequences, these rewards are known as positive reinforcers. Food, water, social affiliation, and 
sexual interactions all activate neural pathways in the brain that are known as the reward system. 
Drugs of abuse also activate reward circuits, often faster and to higher levels than natural 
rewards, such that drug-seeking can supplant more adaptive behaviors in the repertoire of most 
animals. Major components of the reward circuitry include mesocorticolimbic (MCL) pathways, 
with dopaminergic cell bodies in the ventral tegmental area (VTA) projecting to the nucleus 
accumbens (NAC) and prefrontal cortex (PFC), with glutamatergic and GABAergic feedback 
loops (Olsen 2011; Yager et al. 2015). Cocaine in particular blocks dopamine (DA) reuptake at 
the dopamine transporter (DAT) (Daws et al. 2002), which results in excess extracellular 
dopamine, and elevated binding at both D1-like and D2-like receptors. Cocaine also blocks 
reuptake of norepinephrine and serotonin, but to a lesser extent (Li et al. 1996; Zhu et al. 2000; 
Sora et al. 2001; Filip et al. 2005). DA transmission remains altered even after the drug is cleared 
from the body (Bossert et al. 2007; Lepack et al 2020). Long term cocaine use also alters 
glutamate transmission (Kalivas et al. 2003) including alterations in adaptation, receptor 
trafficking, and plasticity in several brain regions in the MCL (Wolf et al. 2016). These long-
term neuronal adaptations after prolonged drug use likely underlie the transition from casual 
drug use to addiction and propensity to relapse. Specifics on how dopamine and cocaine alter the 
reward system will be explored in detail later on in this dissertation. Of additional interest for 
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this dissertation is how cocaine, dopamine, and the gut exert their combined effects on altering 
the reward system, drug addictive behaviors, and behavioral reinforcement.  
1.5 The Gut Microbiota 
 The gut microbiota is the collective term used to describe the ecosystem of 
microorganisms living inside an animal’s gastrointestinal tract. Its constitution is substantial, 
with trillions of individual organisms equaling over 100 times the number of genes in the human 
genome (Gill et al. 2006, Borre et al. 2014). While some variability in composition depends on 
the upbringing and environment of the individual host organism, core groups of microbes are 
found in all mammalian species (Gill et al. 2006). Gut dysbiosis is a term used to define 
alterations of the intestinal microbiota with detrimental consequences, such as a loss of overall 
microbial composition, expansion of populations of harmful microorganisms, and/or loss of 
beneficial microbes (Petersen et al. 2014). Gut dysbiosis can lead to irritable bowel syndrome, 
increased gut inflammation, and changes in food metabolism, among other ailments (Yatsunenko 
et al. 2012). 
 Outside of the gut it has become clear that gut microbiota has influence on the brain and 
subsequently behavior (Cryan et al. 2012), leading to the prediction that the gut-brain axis may 
influence neuropsychiatric disorders. Specifically, animals with experimenter-induced gut 
dysbiosis show heightened anxiety-like (Diaz Heijtz et al. 2011, Neufeld et al. 2011) and 
depression-like behaviors (Arseneault-Bréard et al. 2011, Naseribafrouei et al. 2014), with 
clinical studies supporting gut-brain links in depression (Jiang et al. 2015), bipolar disorder 
(Evans et al. 2017) and autism spectrum disorder (Benach et al. 2012, Rosenfeld et al. 2015). 
Recently, evidence has emerged that sensitivity to drugs of abuse is also correlated with changes 
in the gut microbiota in mice and rats (Kiraly et al. 2016; Ning et al. 2017). Clinical reports also 
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show distinct microbiota profiles in cocaine users vs. cocaine-naïve counterparts (Volpe et al. 
2014). While the above studies have established a relationship between SUD and the microbiota, 
they are limited in some capacities. Conditioned place preference (CPP) used to show links 
between drug reward and gut microbiota in mice and rats is a valid classical conditioning model, 
but it does not capture either the compulsion of an animal to seek out a substance or the 
reinforcing effects of that stimuli. Publications are lacking on a relationship between the gut 
microbiota and drug-seeking behavior measured by the self-administration and reinstatement 
model and gut health (specifically the gut microbiota milieu). 
1.6 Specific Aims  
We plan to test the hypothesis that drug use and microbiota composition are linked in 
such a way that microbiota profiles can predict susceptibility to drug use, and that drug use alters 
microbiota composition, hence resulting in a vicious cycle of drug use and abuse. This 
overarching hypothesis will be tested through three specific aims. 
1.6.1 Specific Aim 1: Test the hypothesis that microbiota composition can predict and 
reflect susceptibility to cocaine addiction in adult male rats.  
We will test this aim by analyzing gut microbiota composition in fecal samples from rats 
that exhibit high vs. low addiction phenotypes, as quantified and described by collaborators at 
The Scripps Research Institute and the University of California, San Diego. We predict that the 
gut microbial profile will differ between addiction-prone vs. addiction-resistant adult rats. 
Furthermore, we predict that specific bacterial taxa will predict future cocaine susceptibility in 
adult rats. 
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1.6.2 Specific Aim 2: Test the hypothesis that depletion of the intestinal microbiota in 
adolescent and adult male rats increases cocaine- related behavioral 
reinforcement. 
We will test this aim by providing oral antibiotic solutions and subsequently measuring 
cocaine-related behavioral reinforcement with the i.v. self-administration and cue-induced 
reinstatement models. We will compare outcomes in adolescent vs. adult male rats, and we 
predict that antibiotic-induced depletion of the intestinal microbiota will increase cocaine-
seeking behavior, with greater effects in adults compared with adolescents. 
1.6.3 Specific Aim 3: Test the hypothesis that probiotic treatment in adolescent and 
adult male rats rescues or reduces levels of cocaine- related behavioral 
reinforcement. 
We will test this aim by providing probiotic supplementation for animals that already 
show gut dysbiosis induced by antibiotics or by giving probiotics to animals as a prophylactic, 
then measuring cocaine self-administration and reinstatement. We predict that probiotics will 
rescue normal levels of cocaine-related behavior in animals that already show antibiotic-induced 
microbial depletion, or reduce cocaine-related behavior in antibiotic-naïve animals. These effects 
are predicted to be more robust in adults compared with adolescents.  
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2 DOPAMINE AND ITS ROLE IN THE BRAIN’S REWARD SYSTEM, ADDICTION, 
AND ASSOCIATION WITH THE GASTEROINTESTINAL SYSTEM 
2.1 Abstract 
The neurotransmitter dopamine is involved in many different mammalian biological 
processes. Dopamine has been considered the principal neurotransmitter in the reward system 
and certain psychomotor stimulants, such as cocaine, function primary on dopaminergic 
signaling in the reward system. Outside of the brain, dopamine plays a role in several peripheral 
processes, including the gastrointestinal tract, where dopamine was first discovered. The goal of 
this chapter is to present dopamine’s role in the reward system in the context of addiction. 
Furthermore, we establish how dopamine’s role in reward is associated with the gastrointestinal 
system and the gut microbiota. Starting with the dopamine structure and life cycle we transition 
to describing dopamine’s function at the receptor level then branch out to discussing dopamine 
circuitry and how it plays a part in drug addiction in the brain. We then briefly discuss how the 
dopamine system develops in mammalian organisms before touching on dopamine in peripheral 
systems, focusing on dopamine and the gut. This chapter serves as a strong background source to 
understanding how manipulating gut homeostasis may alter dopamine systems. Furthering this 
understanding of how cocaine abuse may be related to gut relate signaling may provide new 
avenues for treating neurological disorders involving dopamine dysfunction. 
2.2 Introduction 
Dopamine is a signaling molecule that plays a key role in respiration, gastrointestinal 
motility, blood pressure, circadian rhythms, voluntary movement, sleep, feeding, reward 
processing, learning, attention, and many other physiological processes – through interactions 
with receptor proteins on neurons and other biological tissues (Carlsson et al. 2001; Iversen and 
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Iversen, 2007; Rubí et al 2010; Tritsch et al. 2012). This classic, small molecule monoamine 
neurotransmitter binds with two main families of G-protein-coupled receptors, located in both 
the CNS and periphery. With such wide-ranging impact throughout the body, dopamine 
dysfunction is at the crux of many neuropathologies. For example, the devastating movement 
disorder, Parkinson’s disease, involves a massive loss of dopamine neurons in the midbrain 
(Ehringer et al. 1960; Surmeier et al. 2017). The genetic mutation that causes Huntington’s 
disease also dysregulates dopamine in the striatum (Cyr et al. 2006), in part through the loss of 
receptors for dopamine. In terms of mental disorders, antipsychotics appear to ameliorate the 
symptoms of psychosis mainly by blocking dopamine receptors in the D2 family (Snyder et al., 
1974; Stawarz et al., 1975). Schizophrenia, among the most challenging mental disorders, has 
been linked to abnormally high DA receptor density, coupled with low prefrontal dopamine 
activity, leading to elevated DA signaling in mesolimbic regions that contributes to both negative 
and positive symptoms seen in this disorder of thought, perception, emotion, and outward 
behavior (Howes et al., 2009). Other neuropsychiatric conditions such as substance use disorder 
are also related to dopamine dysregulation. Drugs of abuse “hijack” midbrain dopamine systems 
to amplify signaling that would normally mediate responses to novel stimuli, natural rewards, 
and even salient stimuli with aversive valence (Koob and Volkow, 2010). Heightened dopamine 
levels are associated with reward, reinforcement, and even euphoria, while subsequent low 
dopamine levels are components of withdrawal, all part of an addiction cycle (Cooper et al. 
2003). Alterations in reward related brain signaling occur during drug seeking tasks (Koob and 
Volkow, 2010). Specifically, neuronal signaling in the prefrontal cortex, a brain region known to 
coordinate higher-order cognitive functions, is compromised in chronic drug users compared 
with healthy controls (Carboni et al. 2001). Other rewarding stimuli, such as high-fat or high-
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sugar foods, also elicit a burst in dopamine signaling from midbrain neurons. It comes as no 
surprise, then, that dopamine dysregulation is identified in obesity. Striatal D2 receptors are 
reduced in obese patients compared to controls (Volkow et al. 2008), and dopamine transmission 
during compulsive overeating is similar to that observed during drug intake (Johnson and Kenny, 
2010). Obesity can alter levels of extracellular dopamine in the nucleus accumbens, stimulate 
dopamine release in response to high fat diet, and may blunt dopamine release in response to 
other stimuli (such as amphetamine) (Geiger et al.2009).  First identified in the 
peripherydopamine’s role in cardiovascular, gastrointestinal, and immune dysfunction is less 
understood. Pioneering work in areas such as the gut-brain axis serves to link peripheral and 
central dopamine function under both healthy and disordered conditions.  
The main goal of this chapter is to introduce the life cycle, signaling mechanisms, brain 
circuits, and peripheral impact of dopamine, with some focus on its role in reward and 
reinforcement. This overview also serves to provide a basic understanding of cocaine, a 
psychomotor stimulant and major drug of abuse. Cocaine’s primary mechanism of action is to 
block reuptake of dopamine, serotonin, and norepinephrine, thereby amplifying their effects on 
the acute timescale thereby compromising their signals over the long run. Furthermore, 
dopamine may interact with gut microbes directly or indirectly, thereby influencing outcomes 
from microbial depletion or amplification with antibiotics or probiotics, respectively, and 
creating a route for direct cocaine impact on gut-brain signaling as well. Ultimately, 
manipulations of gut microbes might alter dopamine systems, providing new avenues for 
treatment of the many neurological disorders involving dopamine dysfunction. 
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2.3 The Synthesis, Release, and Inactivation of Dopamine  
The lifecycle of neuroactive molecules includes synthesis, storage, release, and 
inactivation. Dopamine is a catecholamine neurotransmitter, i.e. a monoamine that contains a 
catechol- aromatic ring with a double hydroxyl group (Moore and Bloom, 1978). Variation in 
functional groups on the R-group distinguishes dopamine from other catecholamines such as 
norepinephrine which has the addition of a hydroxy group on the second carbon (Moore and 
Bloom, 1979). The dopamine lifecycle has been characterized and illustrated very well in the 
past (Figure 2.1.) (Jones et al. 2014). 
Synthesis of dopamine initiates with the conversion of tyrosine from the diet (Daubner et 
al., 2011). A full diagram of the synthesis of dopamine from tyrosine is shown (Figure. 2.1). 
Tyrosine comes from many components of the diet, with sources including grains and protein-
rich foods such as dairy and meat. Tyrosine is converted into DOPA via tyrosine hydroxylase 
which adds a hydroxyl group to the aromatic ring. DOPA is then converted into dopamine via 
aromatic amino acid decarboxylase which removes the aldehyde group. Dopamine can then 
further be converted into norepinephrine via dopamine-beta-hydroxylase with adds a hydroxyl 
group to the first carbon. Systemic tyrosine levels do not seem to alter catecholamine levels, 
contributing to conclusions that the action of tyrosine hydroxylase is the rate limiting step in the 
formation of dopamine and norepinephrine (Medicine et al., 1994). Dopamine can also be 
synthesized indirectly from the amino acid phenylalanine (Matthewset al. 2007; Moss et al 
1940). Dopamine synthesis is primarily carried out in the gastrointestinal tract but also in brain 
and spinal cord (Hou et al. 2016), making it available for CNS function despite its inability to 
cross the blood-brain barrier (Hardebo et al. 1980). 
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Figure 2.1Dopaminergic synapse and dopamine metabolism 
 (a) (1) In the presynaptic terminal of dopaminergic neurons, tyrosine is transformed into L -
DOPA by the action of tyrosine hydroxylase. L -DOPA is subsequently transformed to the 
neurotransmitter dopamine (DA) by action of the DOPA decarboxylase. DA is then transferred 
in vesicles by the vesicular monoamine transporter 2 (VMAT-2). After exocytosis of the DA 
vesicles, DA binds to DA receptors on the postsynaptic membrane, leading to the transduction of 
the signal in the postsynaptic neuron. DA is then recycled by reuptake via the DA transporter, or 
catabolized by the action of monoamine oxidase (MAO), cathecol- O -methyl transferase 
(COMT) and aldehyde dehydrogenase (AD) enzymes. The dopaminergic synapse is the principal 
site of action of current PD treatments. By increasing dopamine metabolism ( l -DOPA 
treatment) or by inhibiting dopamine catabolism (COMT or MAO inhibition), or by directly 
activating postsynaptic dopamine receptors, these treatments boost the activity of the 
dopaminergic synapses. (b) Illustrates the lifecycle of dopamine starting with tyrosine acquired 
from the diet. Dopamine can then also be a precursor for other neuroactive molecules 
(norepinephrine) or be broken down through several mechanisms (MAO,COMPT,AD) (adapted 
from Jones et al. 2014). 
 
In neurons, tyrosine hydroxylase is synthesized the cell body (Fernstrom et al. 2007), then is 
transported to the nerve terminal where it converts tyrosine to DOPA (Gervasi et al. 2016; Jarrott 
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and Geffen, 1972). Dopamine-synthesizing cells exist in many parts of the brain with major 
groupings in the ventral midbrain and in the hypothalamus (Juárez Olguín et al., 2016). 
Once synthesized in the nerve terminal, dopamine is packaged into vesicles for synaptic 
release. Dopamine is transferred into the synaptic vesicle via vesicular monoamine transporter 
(VMAT)(Best et al. 2009; Daubner et al. 2011) which uses a form of active transport that relies 
on a H-ATPase to create an electrochemical gradient by promoting influx of protons into the 
synaptic vesicles. This gradient drives neurotransmitter into the vesicle (Kandel et al., 2012), 
creating a high density of some 100,000 times more in the vesicle than in the cytoplasm. 
Dopamine release is usually triggered via calcium signaling from arriving action 
potentials at the nerve terminal (Daubner et al. 2011). Dopamine can also be released at the soma 
and dendrites, but to a lesser extent (Bergquist et al., 2003; Crocker, 1997). Dopamine neuronal 
firing and release can occur at a very low frequency (tonic) or at brief, higher frequencies 
(phasic) (Grace and Bunney, 1984; Rice et al., 2011). Functionally, it has been shown that phasic 
activity encodes prediction-related information (Schultz, 1998; Schultz et al., 1993) whereas 
tonic firing underlies the steady-state level of extracellular dopamine in subcortical structures. In 
essence, tonic release maintains homeostatic dopamine signaling that can restore DA receptors 
back to normal levels. Being that most tonic release is governed by cortical striatal afferents, this 
top-down control regulates dopamine homeostasis (Grace, 1991). 
Presynaptic autoreceptors contribute to the regulation of release rates using negative 
feedback mechanisms. Synaptic dopamine release is often accompanied by co-release of other 
transmitters. For example, glutamate can be co-released along with dopamine (Broussard, 2012), 
resulting in not only excitation downstream (EPSPs) but also postsynaptic modulation 
(Broussard, 2012; Chuhma et al., 2004). Small peptides such as cholecystokinin can modulate 
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release and be co-released with dopamine (Marshall et al., 1991). In the synaptic cleft, dopamine 
binds to pre- and post-synaptic receptors, with five main families of receptor proteins (see next). 
Dopamine activity in the synapse is terminated either by metabolizing synaptic dopamine 
into non-active metabolites or by presynaptic reuptake. Breakdown in the synapse or cytosol is 
catalyzed by catechol-o-methyltransferase (COMT). COMT converts dopamine into 3-
methoxytryramine which is then subject to conversion by monoamine oxidase (MAO) into 
homovanillic acid, which is readily excreted (Koreen et al., 1994). COMT modifies all 
catecholamines by adding a methyl group to the R-group. Another way dopamine is broken 
down is through deamination by monoamine oxidase (MAO), forming dihydroxyphenylacetic 
acid (DOPAC). Inactivation by presynaptic reuptake of monoamines is carried out by transporter 
proteins. The dopamine transporter (DAT) is embedded in presynaptic membranes, mainly on 
axon terminals outside the synaptic cleft (Cooper et al., 2003) and uses a Na/K-ATPase and an 
existing Na gradient to fuel transport from the cleft into the nerve terminal cytoplasm (Torres et 
al., 2003). Sodium gates this action by binding to DAT to change its confirmation, allowing 
dopamine to pass (Sonders et al., 1997). 
2.4 Dopamine Receptors 
2.4.1 Postsynaptic receptors 
Dopamine receptors have two main subcellular locations, post-synaptic receptors 
embedded in post-synaptic membranes to mediate downstream signaling, and pre-synaptic 
autoreceptors positioned on presynaptic membranes to provide autoregulatory feedback on 
dopamine synthesis and release. There are two families of post-synaptic receptor proteins and 
five main receptor subtypes (Beaulieu and Gainetdinov, 2011; Tritsch and Sabatini, 2012); all 
have seven transmembrane-spanning domains and are G-protein coupled on the intracellular 
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surface. The two families of receptors are D1- and D2-like receptors, found in all dopaminergic 
pathways but with different expression levels (Hall et al., 1994). The D1-like family consists of 
D1 and D5 receptors, which share structural similarity and cannot be distinguished 
pharmacologically. These receptors couple with stimulatory G-Proteins (Gs-alpha and Golf) 
(Tiberi et al., 1991), which trigger adenylyl cyclase and lead to production of cAMP and 
activation of PKA (Neve et al., 2004). The result of this cascade is usually the formation of 
EPSPs. While D1 and D5 receptors are similar, they do differ in terms of expression and affinity. 
An example is that D1 receptors localize in dendritic spines and D5s are expressed in the nerve 
terminals of the basolateral amygdala (Muly et al., 2009). Such subcellular differentiation may 
impart circuit specificity, as this phenomenon of localization on different parts of the neuron is 
seen in many other brain regions, such as substantia nigra, hypothalamus, and caudate/putamen 
(Bergson et al., 1995). In the prefrontal cortex, D1 receptors are much more highly expressed 
compared to D5 (Kandel et al., 2012). With regard to affinity, D5 receptors have a ten times 
higher affinity for dopamine compared to D1 receptors (Cooper et al., 2003).  
The second main family of dopamine receptors is D2-like receptors: D2, D3, and D4. D2 
is highly expressed in the brain, whereas D3 and D4 on the whole are more sparse. D2 receptors 
are mostly located in the striatum. D3 receptors are found mostly in limbic circuits (Cooper et 
al., 2003). D4 receptors may be concentrated most in pyramidal neurons in the cortex (Neve et 
al., 2004; Oak et al., 2000; Wang et al., 2002). In contrast to D1-like receptors, D2-like receptors 
activate inhibitory G-proteins (Gi) which when dissociated inhibits adenylyl cyclase and limits 
PKA activation (Neve et al. 2004). D2-like receptor affinity for dopamine is about 100x more 
than for D1s (Titsch et al. 2015) which results in a higher chance of inhibitory dopamine 
cascades in locations where D1- and D2-like receptors are both present. While no ligand can 
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fully differentiate between individual receptor types, several medications target one type of 
receptor vs another (Cooper et al., 2003). An example is clozapine that has its highest affinity for 
D4 receptors but can still bind to other receptors in the D2- like family (Cooper et al., 2003). 
Both D1 and D2 dopamine receptor subfamilies are subject to receptor up- and down-
regulation under conditions of diminished or heightened receptor binding with dopamine or its 
exogenous agonists. Chronic exposure to dopamine receptor antagonists also increases the 
number of postsynaptic receptors. Conversely, chronic exposure to dopamine agonists decreases 
binding sites (Cooper et al., 2003). In general, increased postsynaptic receptor stimulation results 
in decreased nigrostriatal dopamine activity. Binding of dopamine to post synaptic receptors 
results in several downstream consequences. When dopamine binds to D1 like receptors, 
dissociation of Golf results in activation of adenylate cyclase , producing the secondary 
messenger cAMP (Tiberi et al., 1991). When dopamine binds to D2 like receptors the opposite 
process occurs resulting in less cAMP production (Neve, 2009). cAMP then has the ability to 
exert its physiological effects on downstream targets through several mechanisms. Perhaps the 
most studied of these mechanisms is modulation of Protein Kinase A (PKA) (Park et al., 2005), 
but recently extensive research has been done on Phospholipase C modulating calcium levels via 
D1 receptor activation (Ha et al., 2012), which has been linked to neuropsychiatric disease 
(Mishra et al., 2018). Descriptions of second messenger pathways activated by dopamine binding 
to post synaptic receptors has been covered extensively (Bibb et al. 2005; Lebel et al. 2009; 
Savica and Benarroch, 2014) (Figure 2.2). 
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Figure 2.2Downstream second messenger signaling of D1 and D2 like receptors 
 
After D1 receptor stimulation, tau is phosphorylated by activation of PKA, cdk5 and GS to 
Gs/Golf and stimulate production of the second messenger cAMP. After the increase in CA 
which binds to definite DNA sequences and modulates the transcription of certain genes. In 
opposition, the D2 class of receptors (D2,D3, and D4) couple to Gi/Go and negatively regulate 
cAMP production, which decreases general PKA activation. D1 but not D2 receptor activation 
will phosphorylate tau. Through a PKA-dependent intracellular mechanism, D1 receptor 
activation will increase intracellular calcium levels, leading to both cdk5 activation by calpain 
proteolysis of p35, and GSK3Beta activation through its phosphorylation at tyrosine 216. Tau 
hyperphosphorylation may impact neuronal synaptic plasticity as cytoskeletal constituents are 
involved in the maintenance of dendritic processes, and any changes in their stability could affect 
major cellular compartments, such as dendrites, spines, and synapses. Plain arrows represent 
activation or increased levels, whereas the broken arrow represents inhibition. (adapted from 
Lebel et al. 2009) 
 
2.4.2 Extrasynaptic dopamine function  
Dopamine may also alter neuronal functioning in other ways besides synaptic binding to 
post-synaptic dopamine receptors. The one-to-one synaptic relationship between two cells only 
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governs a portion of synaptic transmission. Previous reports show that extra-synaptic 
neurotransmitter modulation occurs frequently with glutamate transmission (Okubo et al., 2010) 
and now it appears the same is true for dopamine transmission (Daniel et al., 2009; Mani and 
Ryan, 2009; Taber and Hurley, 2014; Vizi et al., 2010). Volume transmission, which is the 
concept that neuroactive substances can diffuse over long distance to reach their receptors (Jan 
and Jan, 1982) has been shown to exist in other types of neural signaling such as in the 
vasopressin system (Albers, 2015). Through volume transmission, dopamine may exert its 
effects on neurotransmitter function indirectly. Examples of these outcomes are modulation of 
vesicular neurotransmitter release via altering axon terminal excitability, calcium signaling, or by 
interreacting with vesicular release machinery (Tritsch and Sabatini, 2012). This modulation of 
neurotransmitter release can happen directly via dopamine exiting the synapse and binding to 
dopamine receptors on cells outside of the synaptic complex (Tritsch and Sabatini, 2012). 
Through this volume transmission dopamine may modulate the modality and trafficking of 
receptors on glutamate neurons. In the case of AMPA and NMDA receptors this is primarily 
through PKA-dependent phosphorylation (Håkansson et al., 2006). Finally, dopamine’s 
widespread effects outside of the synapse may influence cells in other networks resting 
membrane potential. 
2.4.3 Autoreceptors 
As mentioned previously, dopamine can also bind to presynaptic autoreceptors. 
Autoreceptors can be present on dendrites, axons, and axon terminals (Cooper et al., 2003). 
Presynaptic autoreceptors can regulate dopamine synthesis via phosphorylation of tyrosine 
hydroxylase (Cooper et al., 2003). Stimulation of autoreceptors on somatodendritic region slows 
neuronal firing rates, whereas stimulation of autoreceptors on the nerve terminal limits dopamine 
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synthesis and release. Most autoreceptors can be classified as D2 autoreceptors, although D1 
autoreceptors may be transiently expressed during development. While autoreceptors and 
postsynaptic receptors are structurally similar, presynaptic autoreceptors are 5-10 times more 
sensitive to dopamine binding. Not all dopaminergic neurons possess autoreceptors, with 
mesocingulate and mesoprefrontal dopaminergic neurons notably lacking autoreceptors. 
Dopaminergic neurons with autoreceptors tend to have higher rates of firing, higher dopamine 
turnover, diminished response to dopamine agonists and antagonists, and lack of receptor 
tolerance to antipsychotic drugs. In summary, dopamine release can act directly/indirectly to 
alter neurotransmitter release (presynaptic) or postsynaptic transmission either through dopamine 
receptors or other neurotransmitter systems. 
2.5 Dopamine circuitry in the brain 
Dopaminergic neurons are found in almost every part of the brain. The five major 
dopaminergic pathways in the brain are the nigrostriatal, mesocorticolimbic, tuberoinfundibular, 
hypothalamospinal, and Incertohypothalamic, with nigrostriatal and mesocorticolimbic being the 
most studied (Beaulieu and Gainetdinov, 2011). In the nigrostriatal pathway, neuronal cell 
bodies are located in the substantia nigra with axonal projections into divisions of dorsal striatum 
(caudate and putamen in primates). Signaling then continues to globus pallidus then to motor 
cortex via the thalamus. Signals from the motor cortex then descend through spinal afferents to 
control motor neuron function, therefore the main function of this pathway is the control of 
movement. Degeneration of neurons in this pathway is a leading cause for several movement 
disorders such as Parkinson’s disease (Kandel et al., 2012). In the mesocortical limbic pathway, 
neuronal cell bodies are located in the ventral tegmental area (VTA), with projections into the 
ventral striatum (nucleus accumbens) as well as areas of frontal cortex modulating behavior 
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(Arias-Carrión et al., 2010). Specifically, these dopamine projections tend to synapse on 
medium-spiny GABAergic neurons which then form a mutually inhibitory network (Geldwert et 
al., 2006). This inhibition which can then directly feedback to the VTA directly or indirectly via 
the ventral pallidum (VP) or hypothalamus is a way to keep the system in homeostasis (long loop 
feedback). The mesocorticallimbic pathway is critical for affect, emotion, attention and 
motivation. Dysfunction in these projections is associated with cognitive disorders, such as 
schizophrenia and drug addiction (Chen and Kandel, 1995). Despite their distinctions, these two 
pathways overlap, and the nigrostriatal pathway may contribute to rewarding behavior just as 
much as the mesolimbic dopamine pathway. For example, electrical stimulation experiments 
show that stimulating either the substantia nigra or the ventral tegmental area is rewarding in rats 
(Crow, 1972; Hoebel and Novin, 1982; Routtenberg and Malsbury, 1969). In fact, the anatomical 
division between the two pathways is blurry (Wang and Morales, 2008),with many researches 
noting that activation of both areas occurs in response to rewarding stimuli. It is suspected that 
reward processing involves both circuits to assist with forming habits, maintaining behaviors, 
and different types of emotional learning needed for reward associations to occur (Wise, 2009). 
The differences in how these two circuits contribute to reward may not only be attributed to 
location of the projection but also the receptor subtypes on the dopamine neurons themselves. 
D1-like receptors are more abundant in the mesocortical limbic pathway, whereas D2 receptors 
are more abundant in areas of dorsal striatum (caudate and putamen). Considering less evidence 
of differences in dopamine synthesis and release in these two pathways, receptor expression may 
be the key to understanding how these circuits operate and contribute differently to reward 
processing. 
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Among the lesser studied pathways, the tuberoinfundibular projection originates in the 
arcuate nucleus and projects to the pituitary gland, with the primary function of controlling 
hormone release. The hypothalamospinal pathway has cell bodies in the hypothalamus that 
connect to T1-L2 of spinal cord. Disruption of this pathway is associated with motor 
dysfunction. The incertohypothalamic pathway has dopaminergic signaling from the zona incerta 
(a subregion of the hypothalamus) to the thalamus and hypothalamus. Not much is known about 
this pathway, but some research has shown it relates to sexual function (Giuliano and Allard, 
2001). 
2.6 Dopamine in reward and reinforcement 
Dopamine is the molecule most extensively associated with the behavioral processes of 
reward, reinforcement, and addiction. Early studies outlined a role for mesolimbic dopamine in 
the initial approach and exploration of appetitive and novel stimuli, thereby aligning its 
transmission with salience attribution. Furthermore, mesolimbic dopamine transmission was 
thought to signal the presence of a reward, given dopamine spikes after initial reward exposure. 
In the early 1990s, this understanding expanded through a series of studies by Schultz and 
colleagues. Monkeys trained to associate a conditioned stimulus cue with an unconditioned juice 
reward showed dopamine surges in the nucleus accumbens before the reward but after the cue 
(Schultz et al., 1993). Although dopamine had initially risen with presentation of the 
unconditioned rewarding stimulus (juice), dopamine neuronal activity migrated toward the 
conditioned stimulus (reward cue) over training trials. The dopamine signal appeared to shift 
throughout the experiment but could be reset after extinction of the relationship between 
conditioned stimulus and unconditioned reward. Thus, it appears as though dopamine acts to 
alert the organism to novelty or error, as in the presence of an unexpected reward or the absence 
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of an expected reward. Dopamine’s role in salience can be extended to both approach and 
avoidance behavior. While animals approach rewarding stimuli, they avoid aversive stimuli, and 
stress-induced activation of both dopamine and glutamate circuitry in the prefrontal cortex may 
contribute to neuropsychiatric disorders, including addiction (Moghaddam, 2002).  
2.6.1 Drugs of abuse 
Drugs of abuse can alter dopamine function at various points in its life cycle of synthesis, 
storage, release, binding and/or inactivation. Psychomotor stimulants tend to amplify dopamine 
transmission either directly or indirectly, as discussed in detail below using cocaine as the prime 
example. While not addressed in this chapter, several other classes of drugs of abuse such as 
opioids and cannabinoids appear to enhance dopamine transmission via the endogenous opioid 
system (Koob, 2001). While the exact mechanisms of how alcohol modulates dopamine 
transmission are currently unclear (Di Chiara, 1997), the opioid and GABAergic systems act as 
intermediaries in pathways from alcohol intake to dopamine activation (Cruz et al., 2008; 
Froehlich, 1997; Tanchuck et al., 2011; Xiao and Ye, 2008). 
Cocaine is a psychomotor stimulant that can be administered in solid form through 
intranasal sufflation of the hydrochloride salt, in liquid form through intravenous injection, or 
smoked from the modified free base form (crack cocaine). Naturally occurring in the coca plant 
of tropical environments such as South America and Southeast Asia, cocaine is a psychoactive 
alkaloid with bitter taste that is likely aversive to insects and other animals. Historical practices 
of chewing on coca leaves results in very low doses of cocaine crossing into blood circulation. 
Intravenous and inhaled cocaine appears in higher concentrations in the blood plasma and at a 
faster rate than cocaine administered through insufflation (Cone, 1995; Jones, 1997). Peak 
concentrations of cocaine in the blood stream varies depending on administration route but 
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usually occurs after 30-100 minutes post administration then starts to decline (Jones, 1997). The 
reported half-life for cocaine is less than one hour. The two major metabolites of cocaine are 
benzoylecgonine and ecgonine methyl ester (Cone, 1995). Cocaine is metabolized by liver 
enzymes and excreted through the urine (Stewart et al., 1979). Cocaine metabolites can be 
detected in the urine approximately three days after initial intake (Chow et al., 1985; Cone et al., 
1998). 
In terms of pharmacodynamics, cocaine binds to the dopamine transporter (DAT) to 
block dopamine reuptake, resulting in prolonged dopamine activity in the synapse (Cone et al. 
1995; Nestler et al. 2005). Cocaine and several other psychostimulants have a structure very 
similar to dopamine in that they possess an aromatic ring and similar R groups. Cocaine also 
binds to the norepinephrine transporter (NET) and serotonin transporter (SERT) but to a lesser 
extent (Kandel et al., 2012), with binding affinity dependent on specific amino acid residues in 
the hydrophobic pocket of the DAT, NET, and SERT (Beuming et al., 2008). Under normal 
conditions, when dopamine binds to the DAT, the gated tunnel of the transporter changes 
conformation in order to transport the bound dopamine into the intracellular space. When 
cocaine is present, the molecule gets trapped on the extracellular open state, preventing the 
conformational change in the gated tunnel (Huang et al., 2009). While cocaine has the ability to 
bind to all monoamine transporters it exhibits the greatest effect on the DAT because it binds 
longest (i.e. it has the highest dissociation constant which stems from different amino acids in the 
binding pocket) (Hasenhuetl et al., 2015). While DAT is found in many parts of the brain, it is 
abundantly expressed in areas of forebrain, ventral striatum, and slightly less expressed in the 
dorsal striatum (Ciliax et al., 1995). It is therefore not surprising that the mesocorticolimbic and 
nigrostriatal pathways are the most influenced by the presence of cocaine or other compounds 
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that act on dopamine transmission and the dopamine transporter. It is possible that cocaine could 
have some direct effects in the gut, given the evidence that DAT exists in the epithelial cells of 
the stomach (Mezey et al., 1999), the colon, and duodenum (Tian et al., 2008). 
Cocaine users report feeling euphoric, energetic, alert, awake, and hyper-responsive to 
sensory stimuli, along with some reports of feeling agitated, irritable, agitated, anxious, 
panicked, or paranoid. Physiological effects related to DAT blockade in the periphery mimic 
sympathetic nervous system activation, including vasoconstriction, dilated pupils, increased body 
temperature, heart rate, and blood pressure. 
2.6.2 Withdrawal and Tolerance 
After cocaine use has ceased, withdrawal is likely to occur. Cocaine invokes numerous 
changes in neurophysiology and behavior. Extraceullular DA (and serotonin) levels in the 
nucleus accumbens drop precipitously initial withdrawal (Parsons et al., 1996; Weiss et al., 2001; 
Weiss et al., 1992). This alteration in NAC activity may be mediated by dampened activity in the 
VTA immediately after withdrawal begins (Ackerman and White, 1990; 1992; Henry et al., 
1989). DA receptors that are downregulated during chronic administration, start to upregulate 
during withdrawal (Kuhar et al 1996) Properties of pre- and postsynaptic neurons may be altered 
as well, with presynaptic neurons showing altered metabolism of glucose at the start of 
withdrawal and other groups showing changes in postsynaptic D1 receptors in the nucleus 
accumbens post-withdrawal (Kuhar and Pilotte, 1996; Neisewander et al., 1995). In humans, 
some evidence has shown that brain physiology is altered during cocaine withdrawal. This is 
mainly assessed through fMRI, where cerebral blood flow in the PFC is decreased in patients 
that initiated cocaine withdrawal compared to controls (Volkow et al. 1988). Behaviorally, 
cocaine withdrawal can alter grooming behavior, locomotion, induce anhedonia, and alter 
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memory related tasks among other things (Markou and Koob, 1992). These signs of withdrawal 
are thought to me mediated not only by dopamine post-synaptic receptor functioning but also 
changes in other neuroactive molecules such as nociception, endocannabinoids, Neuropeptide Y, 
vasopressin, Substance P ,and norepinephrine (Koob and Volkow, 2010; Markou and Koob, 
1991). This is not surprising given the vast crosstalk between dopamine and other 
neurotransmitter systems. One common trait of withdrawal is the near immediate changes in 
drug related behavior and neurophysiology with the body’s attempt to maintain homeostasis 
(Kuhar and Pilotte, 1996). In short, the physiological response to withdrawal is the body’s 
attempt to bounce back to a period of homeostasis that was perturbed by chronic drug use. 
Tolerance to cocaine is another hallmark of addiction defined by the DSM 5. Tolerance 
by definition is a diminished response to the same input stimuli. Tolerance usually is seen in 
laboratory animals after 10 days of chronic cocaine administration (Hammer et al., 1997). It is 
thought that a reduction in basal dopamine neurotransmitter (Imperato et al., 1992; Maisonneuve 
et al., 1995), a reduction in stimulated release (Inada et al., 1992; King et al., 1994), and an 
alteration of dopamine receptors and second messenger systems all contribute to cocaine 
tolerance (Goeders and Kuhar, 1987; Hammer et al., 1997; Volkow et al., 1993). It is also 
thought that the opioid system may be involved with the dopamine system to instigate tolerance 
(Nestler, 2005). Behaviorally, tolerance results in drug intake or approach that results in a shift in 
the dose response curve to the right (Wood and Emmett-Oglesby, 1986). Tolerance can be 
achieved in self-administration studies by allowing animals to self-administer for a period of 
time, then injecting the animal with high doses of cocaine, then observe subsequent behavior. 
When animals are tested again, both fixed ratio (Emmett-Oglesby and Lane, 1992) and 
progressive ratio (Li et al., 1994) challenge tests reveal a shift in the dose response curve that 
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returns to normal after 1-2 weeks. Rodent subjects also had lower reward thresholds when 
measured by intercranial self-stimulation during a state of tolerance vs no drug exposure or 
cocaine exposure (Kokkinidis and McCarter, 1990). 
Other major psychomotor stimulant drugs include amphetamine, methylphenidate, 
nicotine, caffeine, and modafinil, among many others. Through direct or indirect action, each of 
these elevates extracellular levels of dopamine, norepinephrine, and serotonin. The therapeutic 
advantages of these drugs and their pharmacological activity are well known, as they are used to 
treat excessive daytime sleepiness (narcolepsy) and attention deficits (attention deficit disorder), 
used recreationally to enhance wakefulness and focus (caffeine), and may suppress some 
symptoms of schizophrenia (as nicotine use is highly comorbid with schizophrenia). Yet, their 
high abuse liability causes billions in healthcare costs related to direct effects (dependence), side 
effects (organ damage), and is associated with myriad detrimental personal consequences related 
to directing resources to obtaining and using the drug.  
2.7 Dopamine system development 
Most dopamine neurons in the brain are located in the midbrain. As such they are called 
mesodiencephalic dopamine neurons. The number of these neurons is estimated to be about 
500,000 (Pakkenberg et al., 1991). Midbrain dopamine neurons are derived from neural tube 
progenitor cells (Ono et al., 2007). Numerous genes and gene products contribute to the 
regulation of dopamine neuron development (Bissonette and Roesch, 2016). Dopamine levels 
fluctuate throughout the life cycle in an inverted u-shape. Dopamine levels rise and peak during 
adolescence. In addition to this peak, dopamine concentrations shift towards more anterior 
regions of the brain as mammals develop (Goldman-Rakic and Brown, 1982). This finding 
mimics the developing brain during adolescence, particularly prefrontal cortex (Spear et al. 
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2000). A consequence of this rise in dopamine during adolescence could be to promote overall 
neuronal excitability via dopaminergic modulation of voltage thresholds for firing (Henze et al., 
2000). Human dopamine receptor data has shown that D1 and D2 like receptor levels decrease 
from childhood to adulthood and in fact get to adult levels by five years of age (Montague et al., 
1999; Seeman et al., 1987). Rodent studies show that dopamine receptor levels peak between 
P28 and P42, then level off or decline (Tarazi et al., 1999; Tarazi et al., 1998). There are some 
discrepancies however to region-specific effects and possible age contributions to certain classes 
of receptors (Wahlstrom et al., 2010). While ample evidence supports a change in the dopamine 
system throughout the lifespan, these data are confined to changes in the CNS. Of interest to this 
dissertation would be to understand whether the timeline of development of dopaminergic 
neurons in the gut could be similar to what we observe in the CNS. 
2.8 Non-neuronal dopamine interactions 
2.8.1 Dopamine and Glia 
While several neuropsychiatric disorders have been linked to dysregulated dopamine 
transmission or loss of dopamine neurons, extensive evidence suggests that non-neuronal cells 
can also play major roles in these pathologies. For example, interactions between dopaminergic 
cells and glial cells have been implicated in neurodegenerative disorders, particularly 
Parkinson’s disease. Dysfunction among glia increases inflammation which may lead to 
dopamine cell dysfunction and/or cell death (McGeer and McGeer, 2008). To that end microglia 
activation may be an early sign of future dopamine dysfunction that may lead to neuropsychiatric 
disorders (Kanaan et al., 2010). Moreover, dopamine and its receptor agonists or antagonists can 
alter membrane potentials and evoke small hyperpolarization in astrocytes (Hösli et al., 1987). 
Alterations on astrocyte function may lead to several pathogenic outcomes, such as loss of 
34 
integrity of the blood brain barrier and an increase in neuro and peripheral inflammation. This 
may be a mechanism on how cocaine induces increases in neuroinflammation (Sil et al., 2019) 
and inflammation in the gut (Chivero et al., 2019). 
2.8.2 Peripheral Dopamine 
Beyond the CNS, dopamine and dopaminergic neurons are found in many parts of the 
periphery. In fact, dopamine was initially identified in the gastrointestinal tract (Carlsson et al. 
1958; Clark and Menninger, 1980). While the substance dopamine was first synthesized and 
identified in the early 1900s, it was not until the 1950s that dopamine was identified as its own 
neuroactive molecule and not just a precursor to norepinephrine (Carlsson, 1993). The first 
identification of a binding pocket for dopamine occurred shortly thereafter, along with 
dopamine’s postsynaptic intracellular signaling through G-protein coupled-receptors acting on 
adenyl cyclase in a molecular cascade (Kebabian et al., 1972). Research in the 1980s and -90s 
focused on dopamine’s role in the cardiovascular system. A breakthrough contribution was that 
dopamine is vital for proper cardiocyte function (Clark, 1981; Clark and Menninger, 1980). 
Dopamine was also shown to alter renal resistance and blood flow, which may alter cardiac 
output, though the mechanism is poorly understood (Gordon et al., 1995). 
The role of dopamine in the gut is extensive, but its influence on gut-brain signaling 
remains to be explored. Dopamine, DAT, and dopamine receptors have all been found in the 
enteric nervous system, specifically in the jejunum and myenteric plexus (Li et al., 2011;). 
Dopamine receptors are also observed in the mucosa (Hernandez et al., 1987) and in gastric 
muscle (Kurosawa et al., 1991). Chromaffin cells in the GI tract contain dopamine receptors and 
it has been speculated that they may be involved in inter-gut communication (Bigornia et al., 
1988). Enteric dopaminergic neurons express tyrosine hydroxylase (TH) and the dopamine 
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transporter (DAT) but lack dopamine β-hydroxylase (Anlauf et al., 2003). Other catecholamines 
such as serotonin, norepinephrine, and their synthesis enzymes and transport proteins are present 
in the gut as well (Gershon, 2004). The purpose of dopamine in the gut is debated, but it appears 
to be involved in relaxing the intestine and intestinal smooth muscle (Grivegnee et al., 1984; 
Lucchelli et al., 1990). In addition, D2 receptor agonists alleviate the severity of symptoms in 
Irritable Bowel Syndrome and Crohn's disease patients, perhaps through a dopamine-mediated 
inhibition of mucosal permeability and muscle relaxation (Tolstanova et al., 2015). Cocaine 
administration leads to increases in inflammation, gut membrane permeability (Chivero et al., 
2019), and blood clots (Siegel et al., 1999),which may ultimately lead to a decrease in blood flow 
and nutrient transfer (Bachi et al., 2017). These acute effects can then lead to a maladaptive 
environment for the gut microbiota, shifting their diversity and abundance (Chivero et al., 2019). 
The irony of these findings is that cocaine was used extensively in antiquity to restore digestive 
and gastrointestinal health (Weil, 1981). In fact, up until the mid-20th century, coca leaves were 
used to alleviate symptoms of diarrhea, constipation, and indigestion (Biondich et al. 2016). 
Several neuropsychiatric disorders such as Autism Spectrum Disorder and schizophrenia are 
shown to be comorbid with gut-related diseases and alterations in the gut microbiota (Sgritta et 
al., 2019). Given that addiction and substance use disorder are also neuropsychiatric disorders, 
the investigation of how the gut microbiota may play into these pathologies is warranted. Links 
between gut dysbiosis and neuropsychiatric disorders (Cryan and Dinan, 2012), including 
substance use disorder (Meckel and Kiraly, 2019), are currently under investigation. Recently a 
hypothesis for a neural circuit for gut-induced reward has been proposed, such that activity in the 
gut influences dopamine activity in the striatum via vagus nerve signaling (Han et al., 2018). 
This pathway passes from the vagal afferents through the right nodose ganglion to the lower 
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medulla then to the striatum and other parts of the midbrain. This pathway deserves detailed 
examination with regard to direct influence of gut health on addiction vulnerability. 
2.9 Conclusions 
Many biological functions have been mapped to dopamine circuits in the brain including 
arousal, attention, motivation, motor control, and executive function. Neuropsychiatric disorders 
and pharmacological substances affect the dopamine system by altering synthesis, trafficking, 
storage, release, reuptake, and/or postsynaptic signaling. With regard to reward and 
reinforcement, dopamine is a detector for salience and error. One main difference between 
natural rewards (food, water, sex, etc.) and addictive drugs (cocaine, amphetamine, nicotine, 
opioids, cannabinoids, alcohol) is that drugs of abuse elevate dopamine levels with great 
amplitude and duration, across a wider range of conditions, and without as much adjustment after 
repeated exposure to the same pharmacological stimulus. Thus, drugs are associated more readily 
with compulsive reward-seeking behavior, withdrawal symptoms, and dependence. Cocaine in 
particular amplifies dopamine signaling by binding to DAT and decreasing presynaptic reuptake, 
leaving dopamine in the synapse for longer periods of time and increasing dopamine 
transmission. While these effects are well-mapped in the brain, to what extent they occur in the 
periphery, especially in the gut, remains to be understood. There is evidence that dopamine 
synthesis and transmission occurs in the gastrointestinal tract. The presence of DAT in several 
parts of the GI tract suggest that cocaine can exert a direct effect on gut function. Altered 
dopamine signaling in the gut may exert additional indirect impact on reward brain circuitry via 
pathways that go through the spinal cord, synapse in the nucleus of the solitary tract (NTS), then 
proceed to the medulla and to parts of striatum. Also, indirectly through its sympathomimetic 
action, cocaine may alter the gut environment via altering peripheral blood flow, inducing 
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inflammation, and increasing intestinal permeability. All of these effects are likely to alter the 
gut milieu and may alter the profile of gut microbes that thrive under cocaine-influenced 
conditions. This altered profile may result in different levels of microbial metabolites which may 
then change gut-brain signals. Alterations of brain states may then lead to maladaptive drug-
seeking behavior, leading the organism to consume more cocaine and perpetuating a vicious 
cycle of addiction. These potential mechanisms may contribute to the influence of the gut 
bacterial environment on long-term vulnerability to drug reward and reinforcement. 
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3 EFFECTS OF A WHITE NOISE STIMULUS ON COCAINE SELF-
ADMINISTRATION, EXTINCTION, AND CUE-INDUCED REINSTATEMENT IN 
ADOLESCENT AND ADULT MALE RATS 
3.1 Abstract 
Adolescent-onset of drug use is associated with deleterious addiction outcomes. In animal 
models, however, removal of aversive states has not been incorporated effectively into 
acquisition procedures, and compulsive drug-taking or -seeking remains relatively unexplored 
among adolescent subjects. We tested a novel method to support acquisition of lever-pressing in 
operant conditioning chambers, as well as a new approach to investigate compulsive drug-taking. 
Adolescent and adult male Wistar rats were catheterized and allowed to acquire lever-pressing 
reinforced by removal of a constant white noise stimulus (4 sessions, 2 hr each). Intravenous 
cocaine infusions were then added to removal of the white noise as a consequence of lever-
pressing (2 sessions). Subsequently, white noise was paired with onset of cocaine infusions 
(PUNISHED) or removed entirely (QUIET). After forced abstinence, extinction responding and 
cue-induced reinstatement of lever-pressing were recorded. Removal of white noise supported 
the acquisition of pressing on the active lever, and cocaine increased rates of pressing in both age 
groups. Effects of white noise as a positive punisher to decrease lever-pressing were more robust 
in adults than adolescents, although overall cocaine intake was similar across age and treatment 
groups. White noise as a punisher did not alter extinction responding, but prior age differences 
with adults responding more than adolescents was replicated. Cue-induced reinstatement was 
reduced among punished rats, regardless of age. White noise as a negative reinforcer supports 
acquisition of lever-pressing, with minimal age differences. White noise as a positive punisher 
decreases lever-pressing and extends to lower rates of cue-induced reinstatement. 
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Note: Brett Daniel, Jillian Dawson, Rapheal Williams, Bonnie Williams, and Kyle Frantz are co-
authors on the work contained in this chapter. 
3.2 Introduction 
Adolescent humans engage in more risk-taking behavior than other age groups (Eaton et 
al. 2006), and experiment the most with drugs of abuse (SAHMSA 2016). Longitudinal and 
epidemiological studies have found that most substance abusers initiated drug taking during their 
adolescent years (Chen and Kandel 1995; Palmer et al. 2009; Winters and Lee 2008), with early 
onset of drug misuse predicting subsequent substance use disorder as well as comorbid mental 
health disorders (Anthony and Petronis 1995; Stockwell et al. 2005). Cocaine, a psychomotor 
stimulant, is a highly abused drug among adolescents (Johnston et al. 2016), and the long-term 
consequences of adolescent cocaine intake may include behavioral, neurochemical, and 
structural changes in the nervous system (Kuhn et al. 2013; Squeglia et al. 2009; Wang et al. 
2013). Using animal models such as intravenous (i.v.) drug self-administration and reinstatement 
after extinction and/or abstinence, both acute and long-term impact of adolescent exposure to 
drugs such as cocaine has been investigated. Some results suggest heightened sensitivity to 
cocaine reward and reinforcement among adolescents compared with adults (Anker and Carroll 
2010; Kantak et al. 2007; Lynch and Carroll 2000). Conversely, others suggest some adolescent 
resistance or resilience (Ator and Griffiths 2003; Frantz et al. 2006; Griffiths et al. 1979; 
Schramm-Sapyta et al. 2009; Shram et al. 2008). It has also been argued that the stimulus 
triggering relapse may be responsible for age-dependent effects (Anker and Carroll 2010). 
Results from our laboratory suggest that adolescent-onset of cocaine, morphine, or heroin self-
administration is associated with lower rates of lever-pressing during subsequent tests of 
extinction responding and/or reinstatement, compared with adult-onset (Doherty et al. 2013; 
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Doherty and Frantz 2013; Li and Frantz 2009). To replicate and extend this work, we explore 
herein a novel method to support the acquisition of lever-pressing in operant conditioning 
chambers and introduce a new approach to investigating compulsive drug intake among 
adolescent and adult male rats. 
An essential element of self-administration studies is acquisition of the interaction 
between the subject and the operandum that allows access to the reinforcer, e.g. acquisition of 
lever-pressing that triggers i.v. drug infusions. Various acquisition procedures are common, 
including spontaneous encounters with the operandum, experimenter shaping of successive 
approximations of the target behavior, autoshaping procedures that periodically present and 
retract the operandum, food restriction and initial use of food reinforcers before transition to drug 
reinforcers, priming injections of the drug itself and/or stress stimuli presented before or during 
the acquisition sessions. Each acquisition procedure has strengths and weaknesses, with many of 
the weaknesses including unknown variability across age groups of interest, e.g. potentially 
greater effects of food restriction in adolescents vs. adults (unpublished data, Frantz Lab), with 
therefore unpredictable impact on subsequent drug intake. In our own experimentation, we 
preferred spontaneous acquisition (Doherty et al. 2012; Doherty et al. 2013; Li and Frantz 2009; 
Shahbazi et al. 2008b), but here we introduce the novel use of a white noise stimulus as a 
negative reinforcer of lever-pressing behavior in a new acquisition procedure. White noise has 
long been used as a constant background stimulus during self-administration sessions, except 
during the time out after reinforced lever presses, when it may have been turned off as part of a 
cue sequence associated with onset of drug infusion. Preliminary observations in our laboratory 
revealed, however, that removal of the white noise as a consequence of lever-pressing was 
actually reinforcing the acquisition of lever-pressing behavior itself, regardless of concomitant 
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drug presentation. We interpreted this outcome as evidence that the white noise was aversive, 
and its removal was serving as a negative reinforcer of lever-pressing. The present experiment 
uses white noise as a reinforcer for both adolescent and adult rats. Given that adolescents appear 
less sensitive to a variety of drug-related aversive stimuli, such as drug conditioned taste 
aversion and aversive drug withdrawal (Doherty and Frantz 2013; Hodgson et al. 2009; O’Dell et 
al. 2007; Schramm-Sapyta et al. 2006; Silveri Marisa and Spear Linda 2006) we hypothesized 
that adolescents would show lower levels of lever-pressing when reinforced by removal of a 
white noise stimulus, compared with adults. 
Addiction is characterized by physical and emotional dependence on an exogenous 
substance, often including escalating drug intake over time and continued drug intake despite 
adverse consequences, with the latter known as compulsive drug-taking and drug-seeking (NIDA 
2014). In order to model the compulsive drug-taking component of addiction, some self-
administration procedures pair drug presentation with aversive stimuli, such as electric shock to 
the paws or i.v. histamine (Holtz and Carroll 2015; Katzir et al. 2007) in “punishment” models. 
A second aim of this study is to introduce the novel use of a white noise stimulus as a punisher of 
lever pressing behavior, and to use these new parameters to compare compulsive drug-taking 
across age groups. As above, removal of white noise was used as a negative reinforcer to 
promote acquisition of lever-pressing, but then it was subsequently eliminated from the 
background noise and used only as a discrete drug-paired cue, presented for 20 sec as a 
consequence of pressing on the active lever. Given lower sensitivity to aversive stimuli among 
adolescents compared with adults, we predicted that any attenuation of cocaine intake associated 
with the white noise “punisher” would be less robust among adolescents than adults.  
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Substance use disorder (SUD) is known as a chronically relapsing disorder, so we also 
explored extinction of lever-pressing in the absence of cocaine after various abstinence periods, 
as well as reinstatement triggered by re-exposure to environmental and discrete cocaine-paired 
cues (Bossert et al. 2013; Shaham et al. 2003). To our knowledge, the effects of drug-paired 
punishers on later extinction and reinstatement have not been reported. If adolescents were less 
sensitive than adults to the negative effects of a white noise punisher, we would expect that their 
extinction and reinstatement would be less affected by prior white noise exposure than it would 
in adults. These results would be coupled, however, with our prior outcomes that adolescents 
reinstate to lower levels of lever-pressing than adults after “forced abstinence” (Doherty et al. 
2013; Li and Frantz 2009). We tested these possibilities by measuring extinction responding and 
cue-induced reinstatement in a within-session extinction and reinstatement procedure in separate 
rats at 1-, 14-, or 30-days after the last self-administration session. 
3.3 Materials and Methods 
3.3.1 Animals 
Male Wistar rats (n=65 adolescents, n=65 adults; Charles River Laboratories, Inc, 
Raleigh, NC, USA) arrived at Georgia State University at either postnatal day 22 (adolescents) or 
postnatal day 70-74 (adults) and were pair housed in humidity and temperature controlled cages 
(Optirat Gen II by Animal Care Systems; Centennial, CO), with a reverse light cycle (12:12 hr, 
lights on at 19:00) and ad libitum access to food and water while in the home cages. Animals 
were weighed daily to assess general health, except during drug recess when they were weight 
twice per week (as below). All procedures were conducted in strict adherence to the Principles of 
Laboratory Animal Care and the National institute of Health Guide for the Care and Use of 
Laboratory Animals 8th edition (Guide for the Care and Use of Laboratory Animals. 8th edition, 
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2011) and approved by Georgia State University’s Institutional Animal Care and Use 
Committee. 
3.3.2 Surgery 
After three days of acclimation to the vivarium, animals were transferred to a surgical 
suite for i.v. catheter implantation. Catheters were assembled as previously described (Roberts 
and Koob 1982) with minor modifications including a shorter length of tubing inserted into the 
jugular vein for adolescents (2 cm) compared with adults (4 cm) (Shahbazi et al. 2008a). All 
surgeries followed aseptic technique. Rats were anesthetized with 3-5% isoflurane and 1.5-3% 
isoflurane for induction and maintenance, respectively. Once a surgical plane of anesthesia was 
achieved, a small mid-scapular incision was made, followed by a ventral neck incision. The right 
jugular vein was exposed, pierced, and catheter tubing was pulled subcutaneously from the 
dorsal surface to the ventral incision. Tubing was then inserted directly into the jugular vein and 
secured with nylon suture thread above and below the insertion point. Incisions were closed with 
wound clips and animals received 0.2ml Timentin (ticarcillin disodium and clavulanate 
potassium; 100 mg/ml, i.v.), 0.2 ml heparinized saline (100 USP units/ 1ml, i.v.), topical 
bacitracin, and carprofen (5mg/kg, s.c.). Two control groups were included: catheterized animals 
that later received saline infusions instead of cocaine in the operant conditioning chambers 
(saline controls) and animals that went through all surgical procedures except the actual catheter 
implantation (sham controls). Animals received twice daily doses of Timentin and heparinized 
saline over three days post-op and then daily for the duration of self-administration to maintain 
catheter patency; adolescents received approximately half of the volume of adults. 
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3.3.3 Equipment 
Behavioral tests were conducted in operant conditioning chambers enclosed in sound-
attenuating, ventilated environmental cubicles (Med Associates, Inc., St. Albans, VT, USA). 
Animals were not provided food or water during self-administration sessions. To start each 
session, the house light was turned on and two levers were extended into the chamber. Presses on 
an inactive lever were recorded but had no scheduled consequences. Presses on the active lever 
triggered a syringe pump (variable speed, Med Associates, Inc., St. Albans, VT, USA) to deliver 
drug solution via a stainless steel swivel (Instech Laboratories, Inc., Plymouth Meeting, PA, 
USA) and polyethylene tubing attached to a catheter portal on each animal’s back. Infusions of 
cocaine (0.36 mg/kg per infusion) were given to animals under a fixed ratio 1 schedule of 
reinforcement. Subjects were weighed daily, and infusion volume was adjusted by changing 
infusion duration, based on a standard 0.1 ml/4s per infusion for a 350-g rat, thereby providing 
0.36 mg/kg cocaine per infusion. Saline controls instead received i.v. saline according to the 
same volume calculations, whereas SHAM controls were not attached to the drug delivery 
tubing. Each reinforced response lit a cue light above the lever, which stayed on for 2 sec. After 
a reinforced press the animals entered twenty seconds of time out (TO20) in which presses on 
levers were recorded with no scheduled consequences. The house light and cue light also were 
not illuminated during TO20. Two sets of infrared photo beams in the front and rear of the cage 
were used to record motor activity during the experiment. Drug delivery and data collection were 
controlled by Med Associates software (Med PC IV). The white noise produced by a generator in 
the chambers was used for multiple purposes. As above, it was ambient background noise that 
was turned off in response to active lever-pressing, as part of the reinforcement cue sequence. 
This occurred for the White Noise Training (WNT) sessions and the Loud Self-Administration 
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(LSA) sessions. In approximately half the rats, it was subsequently removed entirely from the 
programming (Quiet Self-Administration; QSA). In the other half, it was switched from ambient 
on/cue off to ambient off/cue on (Punished Self-Administration; PSA), as below. 
 
Note that adolescent-onset groups were young adults by the time of extinction, reinstatement, 
and sacrifice. 
 
 
3.3.4 Lever-press training with white noise as a negative reinforcer and transition to 
cocaine self-administration 
Per the experimental timeline in Figure 3.1, white noise training (WNT) in the operant 
conditioning chambers began three days after surgery. All testing was done at the beginning of 
the dark phase with 2-hr daily sessions over four days. White noise was present in the chamber 
throughout the session, but pressing on the active lever turned off the white noise (and house 
light) for the duration of T020. Following the four days of WNT, animals underwent two days of 
“loud cocaine self-administration” (LOUD; LSA), in which pressing on the active lever not only 
turned off the white noise (and house light), but also triggered an i.v. infusion of cocaine. 
3.3.5 Cocaine self-administration with white noise as a positive punisher 
Upon the conclusion of LOUD conditions, animals underwent eight days of cocaine self-
administration in either PUNISHED (PSA) or QUIET (QSA) conditions. In PSA conditions, 
sessions began with the house light on and levers extended, but no white noise. Active lever-
presses resulted in a 2 sec burst of white noise, along with presentation of the cue light and a 
Figure 3.1 Timeline of experimentation plots self-administration, abstinence, extinction, 
and reinstatement 
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cocaine infusion. The QSA conditions were the same as PUNISHED except that white noise was 
never turned on in the session. Saline and sham controls were tested only in QUIET conditions.   
WNT and cocaine self-administration took place on weekdays only, with two-day 
recesses after the WNT and after the first three days of PSA or QSA. Catheter patency was 
confirmed in all subjects by full loss of muscle tone within 5 s of i.v. infusion of the short-acting 
anesthetic agent, 1% methohexital sodium, during these recesses and after the last self-
administration session. Subjects that failed any catheter test were eliminated from the study. 
3.3.6 Abstinence, Extinction, and cue-induced reinstatement 
At the completion of self-administration, rats entered abstinence periods of either 1, 14, 
or 30 days, during which they were handled and weighed twice per week. At the end of 
abstinence, a within-session extinction and reinstatement test was conducted (Grimm et al. 2001; 
Grimm et al. 2003). Five 1-hr extinction sessions were separated by five-minute breaks during 
which the levers retracted, and the house light turned off. During extinction, rats were connected 
to the metal coil tether but not the infusion tubing; white noise remained off, and the house light 
remained on. Presses on the active lever were recorded, but no drug was infused, nor were any 
cues presented. SHAM controls where not attached to the tether. To allow adequate time for 
blood collection, perfusion, and brain extraction; initiation of extinction session start times were 
staggered approximately 25 min between animals. For cue-induced reinstatement, animals were 
tested in the same procedure as QUIET self-administration except no drug solution was infused 
and no syringe was attached to the pump. No white noise “punisher” stimuli were administered 
to any subjects, allowing test of the enduring impact of prior punishment, rather than acute 
effects of the punisher. 
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3.3.7 Corticosterone analysis 
After the last behavioral test, blood samples were collected from the saphenous vein, 
centrifuged (20,000 RPM, 20 min, Eppendorf 5415R), and plasma stored at -20 °C until ELISA 
for corticosterone levels, according to the manufacturer’s instructions (ab108821: Abcam; K014; 
Arbor Assays). Absorbance was read at 405 nm (Bio-Rad iMark Plate Reader). Internal quality 
controls were assessed using internal kit control, and plate control was assessed by conducting 
analysis in triplicate. Sample control was assessed by devoting two standards to serum taken 
from adolescent and adult rats that had neither cocaine nor behavioral testing. 
3.3.8 Statistics 
Self-administration data were analyzed via mixed-models analysis of variance (ANOVA) 
on active lever-presses, inactive presses, cocaine infusions, and total cocaine intake. The 
ANOVAs were 2x2x2x3 design with age (adolescents vs adults), drug (cocaine vs saline), and 
punishment (noise vs no noise) as between-subjects variables, and session (e.g. extinction 
sessions) as a within-subjects variables, as appropriate. For considerations across experimental 
phases, lever-pressing was averaged over days in each phase (WNT, LOUD, QUIET/PUN). 
Change in lever-pressing in LOUD vs. QUIET/PUN phases was also compared, using 
independent samples t-tests, as was total cocaine intake and plasma corticosterone. All data were 
analyzed using SPSS v.23 (SPSS, Chicago, IL). Post-hoc tests were conducted to identify 
individual differences. Alpha was set at 0.05. All Figures were generated using 
Graphpad/PRISM V.7. 
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3.4 Results 
3.4.1 Active lever-presses 
The two control groups (saline and sham) were compared over all self-administration 
phases by averaging active lever-press data over sessions in each phase. Separate t-tests with 
Bonferroni’s correction revealed no differences in any of the phases (data not shown). Thus, 
saline and SHAM animals were collapsed into a single control group for all subsequent analyses. 
Overall differences between controls and cocaine groups were assessed using a four-way 
ANOVA on active lever-presses, which revealed a significant main effect of drug condition 
F(1,123)= 16.12, p<.001 as well as a drug x session interaction F(1,123)=23.19, p<.001. Data 
were averaged across phases and compared by individual t-tests with Bonferroni’s correction to 
reveal no drug treatment effects during WNT t(127)=-0.647,p=0.52, but significantly higher 
presses among cocaine groups than controls during LOUD (t(127)=8.60,p<0.001) and during 
QUIET/PUNISHED (t(127)=8.57,p<0.001). These data show that all rats acquired lever-pressing 
to the same degree during WNT, but the introduction of cocaine supported reinforced presses on 
the active lever, whereas saline infusions (or no infusions) did not, as expected (Figure 3.2). 
Controls were not included in subsequent analyses.   
With focus on subjects that entered the QUIET cocaine conditions (Figure. 3.2, left 
panels), a two-way age x phase ANOVA shows a main effect of phase (F(2,84)=20.37,p<0.001), 
but not age and no interaction. With data collapsed across ages, all phases are different from each 
other, such that WNT is lower than LOUD t(96)=-8.92, p<0.001 and lower than QUIET 
t(96)=6.67, p<0.001, and LOUD is greater than QUIET t(96)=-7.83, p<0.001).  
On the other hand, for subjects that entered the PUNISHED cocaine conditions (Figure. 
3.2, right panels), a two-way age x phase ANOVA shows a significant interaction 
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(F(2,102)=7.77, p=.001), leading to individual t-tests for age differences in each phase, with 
adults greater than adolescents in WNT (t(51)=-2.86; p=.006) and LOUD phases (t(51)=-
2.30;p=.026), but not once the punishment is actually introduced (t(51)=-0.43;p=0.67). 
Differences across phases within adolescents showed that WNT is lower than LOUD (t(24)=-
5.36; p<0.001) and lower than PUNISHED (t(24)= -4.56; p<0.001), and LOUD is greater than 
PUNISHED (t(24)=4.45; p<0.001). Similarly, differences across phases with adults showed that 
WNT is lower than LOUD (t(27)=-6.53; p<0.001) and lower than PUNISHED (t(27)=-3.21; 
p<0.001), and LOUD is greater than PUNISHED (t(27)=6.22; p<0.001).  
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Figure 3.2 Lever-pressing and cocaine intake during two-hour test sessions 
Panels a and b: Whereas no differences in lever-pressing during WNT were observed across 
treatment conditions, cocaine groups pressed more on the active lever than controls when 
cocaine was available (starting with LSA1), regardless of age or noise conditions (marked on 
Panel a: †††p<0.001). Lever pressing differed across the three phases of self-administration for 
both quiet and punished groups, with the highest rates of responding during LSA (###p<0.001), 
then QSA, then WNT. In the punished subgroup, adults pressed more than adolescents in WNT 
and LSA (*p<.05). Panels c and d: Inactive lever-pressing did not differ across cocaine groups 
vs. controls, although a main effect of age was observed, with adolescents pressing more than 
adults when cocaine was available (marked on Panel c: *p<0.05). Panels e and f: Cocaine 
groups earned more infusions than controls when cocaine was available (marked on e: 
†††p<0.001). Reinforced presses/earned infusions were higher in LSA than the other two phases 
(#p<0.05, ###p<.001), regardless of noise condition, but neither the number of infusions nor 
total cocaine intake differed across age groups. Points and bars represent mean ± SEM. 
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3.4.2 Inactive lever-presses 
An overall four-way age x phase x drug x noise condition ANOVA on inactive lever-
presses revealed main effects of age (F(1,123)=5.73, p=0.018), phase (F(2,246), p<0.001), and 
drug (F(1,123)=16.12, p<0.001), as well as several two-way interactions: phase x age interaction 
(F(2,246)=5.08, p=0.007); phase x noise interaction (F(2,246)=4.70, p=0.01); and phase x drug 
interaction (F(2,246)= 19.57, p<0.001). Pursuing the age differences, adolescents pressed more 
than adults when cocaine was available, as evidenced by a two-way phase x age interaction 
among cocaine experienced groups only (t(95)=2.83;p=0.006, and subsequent t-tests with 
Bonferroni’s correction on age differences during LSA and QUIET/PUNISHED phases (p<.05; 
Figure. 3.2, middle panels). Given that no main effect of drug condition was observed, nor any 
interactions with drug condition, we conclude that inactive lever-presses do not differentiate 
cocaine-experienced rats from controls, and they are not considered further. 
3.4.3 Cocaine infusions and cocaine intake 
Cocaine infusions were analyzed next, using “reinforced responses” as a substitute during 
WNT when no cocaine was available (Figure 3.2, bottom panels). For this variable, an overall 
four-way age x noise x drug x phase ANOVA revealed a main effect of drug condition 
(F(1,123)=16.12,p<.001), along with main effects of age (F(1,123)=5.73,p=.018) and phase 
(F(1,123)=48.73,p<.001), as well as phase x age, phase x drug, and phase x noise condition 
interactions. Data were collapsed across age and noise condition to compare cocaine vs. control 
groups in each self-administration phase separately and showed no significant differences in 
WNT (t(127)=0.27; p=0.79). Yet the cocaine group took more infusions than controls in the LSA 
phase (t(127)=3.87,p<0.001) and QUIET/PUN (t(127)=7.15,p<.001). These data suggest that all 
rats acquired lever-pressing to the same degree during WNT, but the introduction of cocaine 
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supported reinforced presses on the active lever, whereas saline infusions (or no infusions) did 
not, as expected. Controls were not included in subsequent analyses.   
With focus on subjects that entered the QUIET cocaine conditions (Figure 3.2, bottom 
left), a two-way age x phase ANOVA revealed a significant main effect of phase (F(2,84)=11.90, 
p<0.001). Regardless of age, reinforced presses were lower in WNT vs. LOUD (t(43)=-3.73, 
p=0.001), WNT vs. QUIET (t(43)=-5.93, p<0.001), and higher in LOUD vs. QUIET (t(43)=2.57, 
p=0.014). These data indicate that adolescents and adults progressed similarly through the 
experimental phases of these QUIET conditions. 
With focus on subjects that entered the PUNISHED cocaine conditions (Figure. 2, bottom 
right), a two-way age x phase ANOVA revealed a main effect of phase (F(2,84)=11.90, 
p<0.001), such that reinforced presses were lower in WNT compared to LOUD (t(52)=-13.98, 
p<0.001) and compared to PUNISHED (t(52)=-6.54, p<0.001), and higher in LOUD vs. 
PUNISHED (t(52)=11.837, p<0.001). As in QUIET conditions, the two age groups progressed 
similarly through these experimental phases. A two-way age x noise condition ANOVA on total 
cocaine intake (mg/kg) revealed no significant age differences (Figure 3.2 insets), as expected 
based on similar numbers of cocaine infusions. 
 
72 
 
Figure 3.3 White noise change score, i.e. the decrease in lever-pressing in transition 
from LSA to QSA (Quiet) or PSA (Punished) 
Animals that experienced white noise as a punisher had a greater change score compared to quiet 
animal counterparts (@p=0.038). Adults that received white noise as a punisher showed a 
significantly greater change score than adults in quiet conditions #p=0.021), and adults in the 
punished conditions had a greater change score than adolescents in the same punished conditions 
(*p=0.044). 
 
A major focus of this investigation is the impact of changing the role of white noise from 
a negative reinforcer to a positive punisher, which occurred in half the subjects during the 
transition from the LOUD self-administration phase to the PUNISHED phase. In the other half 
of the subjects, white noise was simply eliminated in transition from LOUD self-administration 
to QUIET. Therefore, we calculated a Change Score according to the formula below and 
compared it using individual samples t-tests (Figure 3.3). The greater the change score, the 
greater the influence of the white noise transition on cocaine infusions. Animals that experienced 
white noise as a punisher had a greater change score compared to quiet condition counterparts 
(F(1,93)=4.41, p=0.038). Adults that received white noise as a punisher showed a significantly 
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greater change score, compared with adults in quiet conditions (t(23.53)=-2.48), p=0.021). 
Finally, adults in punished conditions showed a greater change score than adolescents in 
punished conditions (t(33.60)=2.09, p=0.044. 
[
(𝐿𝑆𝐴𝑉𝐸̅̅ ̅̅ ̅̅ ̅̅ ̅ − 𝑃𝑈𝑁 𝑜𝑟 𝑄𝑢𝑖𝑒𝑡 𝐴𝑣𝑒 ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅)
𝐿𝑆𝐴𝑉𝐸̅̅ ̅̅ ̅̅ ̅̅ ̅
]  ×  −100 
3.4.4 Extinction and reinstatement after abstinence 
Cocaine seeking was assessed in five 1-hr extinction sessions followed by a single 
reinstatement session after 1, 14 or 30 days of forced abstinence (Figure 3.4). A 5-way age x 
drug condition x abstinence period x noise condition x session ANOVA on active lever presses 
during extinction revealed a main effect of drug (F(1,111)=14.55,p<.001), so control groups 
were eliminated from subsequent analyses. A follow-up 4-way age x noise condition x 
abstinence period x session ANOVA revealed a main effect of session (F(5,190)=20.98,p<.001) 
and an interaction between age x session (F(5,190)=4.02,p=.002), but no effect of abstinence 
period or noise condition. Within the subjects previously tested in QUIET self-administration 
conditions, no age effects were observed on the individual extinction session, nor the 
reinstatement session (Figure 3.4, left panels). Within the subjects from PUNISHED conditions, 
the only age effect within a single session was observed in the first extinction session after the 
14-day abstinence period (Figure 3.4, right panels). Given no robust differences over abstinence 
period, data were collapsed and analyzed with a 2-way age x noise condition ANOVAs on total 
extinction and the single reinstatement session (Figure 3.5). Extinction testing revealed a 
significant main effect of age (F(1,85)=7.18,p=0.009) but not noise, such that adults made more 
extinction presses than adolescents overall. For cue-induced reinstatement, a significant main 
effect of noise (F(1,85)=10.73, p=0.002) but not age was observed, such that the prior QUIET 
conditions supported greater rates of reinstatement than the prior PUNISHED conditions. 
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3.4.5 Plasma corticosterone  
By the end of experimentation, CORT levels (pg/ml) did not differ significantly by age, 
noise, drug treatment, or abstinence period (data not shown). For example, for all quiet condition 
rats with viable blood samples for analysis, the mean was 317.3 +/-38.8 (n=46), whereas for all 
punished condition rats with viable blood samples, the mean was 269.6 +/-28.4 (n=40). Parsing 
the groups by age instead, adolescents showed 287.04 +/-31.3 (n=51), whereas adults showed 
306.88 +/-40.1 (n=35). Data not shown. 
3.5 Discussion 
The present experiments test the role of white noise as a negative reinforcer during 
acquisition of lever-pressing and as a positive punisher in a new model of compulsive drug-
seeking. The initial phase of the self-administration procedure, white noise training (WNT), 
demonstrates that removal of white noise is effective at promoting the acquisition of lever-
pressing in an operant conditioning chamber. When removal of white noise was combined with 
cocaine infusions as potential negative and positive reinforcers of lever-pressing, respectively, 
the number of presses increased significantly, as expected, again with significant age differences 
only in the group that would subsequently receive white noise punishment. 
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Figure 3.4 Animals that self-administered cocaine had greater extinction responding 
(p<0.01) and reinstatement (p<0.01) than control rats 
Among those that self-administered, adults pressed more than adolescents in the first hour of 
extinction, regardless of abstinence period or noise conditions (EXT1; main effect of age not 
marked, p<0.001). Quiet conditions were associated with higher levels of reinstatement than 
punished conditions (REIN; main effect of noise condition not marked, p<0.001). Specific 
interactions were observed at 14-day abstinence in the punished conditions (**p<0.01). Points 
represent mean ± SEM. 
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Figure 3.5 Total active lever-pressing in extinction and reinstatement averaged over 
abstinence periods 
In extinction, adults (black bars) pressed more than adolescents (white bars) in punished 
conditions (**p<0.01) and tended to press more in quiet conditions (p=0.077). In reinstatement, 
animals in quiet conditions pressed more than those in punished conditions, regardless of age or 
abstinence period (##p<0.01). 
 
Testing white noise as a positive punisher in the next phase of the experiment produced 
interesting results; among adults but not adolescents, white noise punishment (PUNISHED) was 
associated with a greater drop (change score) in lever-pressing than simple removal of the white 
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noise stimulus (QUIET). The punishment-associated change score was also greater in punished 
adults than in punished adolescents, supporting our hypothesis that adolescents are less sensitive 
to the aversive white noise stimulus, while suggesting that acute punishment can suppress drug 
intake. Moreover, the impact of punishment extended into cue-induced reinstatement of lever-
pressing after abstinence, such that rats in the punished group pressed less than those in the quiet 
conditions, regardless of age group, a result that has important translational implications.  
White noise training is a new option for the acquisition phase of operant conditioning. 
The lever-pressing reinforced by removal of a constant auditory stimulus showed consistency 
over sessions, discrimination between active and inactive levers, and rapid transition to a new 
reinforcer (cocaine) after two sessions of simultaneous presentation (LOUD). Levels of cocaine 
intake during loud conditions were consistent with previous reports from our laboratory when the 
removal of white noise was used as a discriminative stimulus signaling time out (Li and Frantz 
2009). With regard to inactive lever-pressing, higher rates among adolescents compared with 
adults during drug self-administration was also previously reported (Doherty and Frantz 2012). 
Overall parallel outcomes across age groups in the rates of cocaine intake are also consistent 
with our prior reports using similar parameters. Therefore, white noise training can be added to 
the existing battery of acquisition procedures, with the novel benefit of demonstrating the 
aversive nature of the auditory stimulus in the same subjects that could be punished with this 
stimulus in a subsequent experimental phase. Optimizing acquisition procedures has been a 
challenge since the inception of experimental models of self-administration, with numerous other 
approaches explored and debated (Carroll and Meisch 2011; Smith et al. 2014). 
White noise is also shown here as a viable punisher in models of compulsive drug-
seeking. The present results are conceptually similar to prior reports with electric shock to the 
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paws or i.v. histamine (Holtz and Carroll 2015; Katzir et al. 2007). These “punishment” models 
may enhance the face validity of research in this area, because they incorporate some element of 
the negative outcomes often faced by human addicts, such as medical, social, financial, and legal 
consequences of drug use and abuse (Blanchard et al. 2003; Treatment 2004). 
The inference in these procedures that white noise is aversive has support from prior 
applications of auditory stimuli in various models and approaches. Noise, by definition, is 
unpleasant, unwanted sound, and has long been recognized as a stressor, with wide-ranging 
deleterious effects on health and well-being, mediated by activation of sympathetic and/or 
endocrine systems (Cucurachi et al. 2012). In laboratory settings, white noise at 92 or 102 dB 
was used in aversive conditioning with human participants, who also filled out an anxiety 
questionnaire confirming discomfort in white noise conditions (Austin and Duka 2010; Austin 
2010). In rodents, auditory stimuli, including white noise, have been investigated as alternatives 
to electrical shock in aversive conditioning models. For example, in the presence of background, 
masking noise of 65 dB, a broadband sound at 105 or 125 dB suppressed lever-pressing 
maintained by food pellet presentation in rats (Reed and Yoshino 2008). Although we are not 
aware of other reports on the use of white noise to shape behavior in adolescent rats, exposure of 
adolescent rats to a high amplitude noise resulted in long-term deficits in hippocampal 
neurogenesis (Jáuregui-Huerta et al. 2011), and adolescents were more sensitive than adults to an 
intensive light stressor (Slawecki 2005). The present results were conducted under conditions of 
approximately 74 dB background sound from airflow systems and operant chambers, elevating 
to approximately 85 db during the white noise stimulus. Age differences under these stimulus 
conditions occurred only in one subgroup of subjects, suggesting that the settings were aversive 
but not as intense as the sound or light stressors in prior reports. Indeed at least by the time 
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plasma samples were collected at the end of the present study, no significant differences in 
CORT were observed across age groups or noise conditions (data not shown). Although tested 
here in presumably prepubescent males, WNT would need to be tested in females, especially 
given suggestions that white noise stress has opposing effects on pain sensitivity in male and 
female rats (Khasar et al. 2005). 
In the transition of white noise from negative reinforcer to positive punisher, the present 
adolescents were less sensitive than adults, as demonstrated by the lesser change score. These 
results are consistent with other data suggesting that adolescent subjects are less sensitive than 
adults to aversive conditions such as drug withdrawal, taste aversion, fear conditioning, and 
pharmacological stressors (Doherty and Frantz 2013; Holtz and Carroll 2015; O’Dell et al. 2007; 
Spear 2011; Spear and Varlinskaya 2005). Yet nuances in the present data set call for further 
exploration. Although significant in only the punished subgroup, lower lever-pressing among 
adolescents compared with adults in both the WNT and LSA conditions of the present 
experiment contributed to the lesser change score among adolescents in the transition to 
punished conditions, calling into question whether the negative reinforcing properties of the 
white noise or the positive punishing properties of the white noise are the less robust in 
adolescents. In either case, however, the age difference relies on the aversive nature of the noise. 
While these results and others cited above suggest that lower sensitivity to aversive stimuli may 
make adolescents less sensitive than adults to negative reinforcement as a driving force on drug-
seeking, adolescents may also be less sensitive to drug-related consequences that essentially 
serve as punishers. The balance between sensitivity to reward vs. sensitivity to punishment has 
long been considered in the context of gating disorders, including drug and alcohol misuse, 
eating disorders, and gambling (Bijttebier et al. 2009; Ernst et al. 2011; Harrison et al. 2010; 
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Soder et al. 2020), and adolescents have been characterized as having a stronger reward 
sensitivity compared with harm-avoidant sensitivity (Ernst et al. 2006). In terms of underlying 
mechanisms, the prefrontal cortex plays a key role in behavioral inhibition (Geier et al. 2009; 
Halladay et al. 2019; Velanova et al. 2008), shows specific changes that distinguish between 
punishment-sensitive or -insensitive rats (Blackwood et al. 2020), and is still maturing in 
adolescence (Casey et al. 2008; Giedd 2004; Giedd et al. 1999; Shapiro et al. 2017; Van Eden 
and Uylings 1985). On the other hand, differential recruitment of striatal subregions across age 
groups may be even more consistent than differential prefrontal activation, based on human 
neuroimaging (Luna et al. 2015). 
Despite the ability of white noise to reduce lever-pressing, its overall effects on acute 
cocaine intake were not significant, as rates of reinforced lever-pressing leveled out similarly 
over eight days of QUIET vs. PUNISHED self-administration, regardless of noise condition or 
age. These results contrast some other investigations of acute punishment, such as the ability of 
co-administration of histamine with cocaine to decrease acute cocaine intake, along with 
subsequent extinction and reinstatement of drug-seeking after abstinence (Holtz and Carroll, 
2015) or the pairing of footshock with drug infusions or alcohol availability that reveals 
punishment-sensitive subgroups of rats or mice (Barnea-Ygael et al. 2012a; Barnea-Ygael et al. 
2012b; Katzir et al. 2007; Le et al. 1999). Again, we conclude that the white noise is aversive, 
but not as robust compared to other punishers of cocaine behavior. Rats in the PUNISHED 
conditions pressed less than their QUIET counterparts when cocaine-associated discrete cues 
were re-presented after abstinence of up to 30 days. These results suggest that even though the 
acute effects of the white noise punishment on cocaine intake were negligible, a latent effect 
emerged after abstinence and extinction. The extinction phase itself confirmed age differences 
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reported by our group and others, such that adolescent-onset groups pressed less than adults 
(Doherty et al. 2013; Holtz and Carroll 2015; Li and Frantz 2009). Mechanisms for a latent effect 
of punishment remain to be explored. In studies on pain sensitivity, though, intermittent sound 
stress enhances pharmacologically-induced hyperalgesia (Khasar et al. 2008), adding another 
possible dimension to the enduring impact of noise exposure. White noise in the self-
administration sessions may have elevated sensitivity to other aversive stimuli later in the 
experimental timeline, such as the anhedonic state of cocaine withdrawal, making rats more 
likely to reinstate drug-seeking as driven by negative reinforcement processes that would 
alleviate withdrawal through reinstatement of drug intake. Moreover, the lack of time-dependent 
increases in reinstatement of drug-seeking (incubation) suggests an additional benefit of 
punishment. Incubation was not observed after quiet conditions either, though, so this could be a 
long-term impact of the white noise training, rather than a punishment effect, used previously.  
Enduring effects of the white noise punisher were observed during the reinstatement 
phase of testing. Rats in the PUNISHED conditions pressed less than their QUIET counterparts 
when cocaine-associated discrete cues were re-presented after abstinence of up to 30 days. These 
results suggest that even though the acute effects of the white noise punishment on cocaine 
intake were negligible, a latent effect emerged after abstinence and extinction. The extinction 
phase itself confirmed age differences reported by our group and others, such that adolescent-
onset groups pressed less than adults (Doherty et al. 2013; Holtz and Carroll 2015; Li and Frantz 
2009). Mechanisms for a latent effect of punishment remain to be explored. In studies on pain 
sensitivity, though, intermittent sound stress enhances pharmacologically-induced hyperalgesia 
(Khasar et al. 2008), adding another possible dimension to the enduring impact of noise 
exposure. White noise in the self-administration sessions may have elevated sensitivity to other 
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aversive stimuli later in the experimental timeline, such as the anhedonic state of cocaine 
withdrawal, making rats more likely to reinstate drug-seeking as driven by negative 
reinforcement processes that would alleviate withdrawal through reinstatement of drug intake. 
Moreover, the lack of time-dependent increases in reinstatement of drug-seeking (incubation) 
suggests an additional benefit of punishment. Incubation was not observed after quiet conditions 
either, though, so this could be a long-term impact of the white noise training, rather than a 
punishment effect. 
In summary, our data suggest that white noise can be used as both a negative reinforcer 
and positive punisher in a rodent model of drug self-administration. White noise at a moderate 
amplitude can be used to promote acquisition of lever-pressing, whereas switching the role of 
white noise from negative reinforcer to positive punisher can attenuate cocaine-seeking behavior. 
Both of these acute effects of aversive white noise are slightly stronger in adults than 
adolescents. At the point of reinstatement after abstinence, though, both adolescent-onset and 
adult groups showed lower levels of drug-seeking after punished conditions compared with quiet 
conditions, suggesting that punishment has latent and enduring effects on cocaine-seeking. 
Further research with these parameters may reveal new approaches to addiction treatment that 
involve mildly aversive sensory stimuli. 
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4 THE GUT MICROBIOTA MILLIEU IS ASSOCIATED WITH COCAINE 
BEHAVIOR VARIABILITY AND PREDICTS SEVERITY OF FUTURE COCAINE 
USE IN ADULT MALE RATS 
4.1 Abstract 
Bacterial communities in the gut participate in a gut-brain axis that influences the 
nervous system. Disruption in the microbial composition is associated with neuropsychiatric 
disorders, including drug abuse. It remains unknown, however, whether gut microbial profiles 
can predict an addiction phenotype before it emerges, or reflect drug experience after it occurs. 
This study used behavioral data and biological samples from the Cocaine Biobank to test the 
hypothesis that the gut microbiota can predict and reflect susceptibility to cocaine reinforcement. 
Adult male rats were catheterized and allowed to acquire lever-pressing maintained by 
intravenous cocaine infusions in 2-hr daily sessions (10 days), followed by progressive ratio (PR) 
testing. Rats were transitioned to long-access daily sessions (6-hr each, 14 days), also followed 
by a PR test and alternating blocks of footshock testing, long-access, and PR. Fecal samples were 
collected at three time points, and sequenced using NGS approaches to test for microbiota 
differences. Specific taxa identified from baseline samples were used as inputs to predict the 
future cocaine susceptibility in naïve animals. As expected, rats varied in levels of cocaine-
related behavior, such that a quartile split identified high and low responders on each measure 
and an overall addiction index. Although beta diversity at baseline and after short access did not 
predict membership in high or low addiction quartiles, linear discriminant analysis (LDA) 
identified specific taxa that were robustly represented in either low or high responders. Beta 
diversity after long access revealed a difference in microbiota profiles between high and low 
responders using multiple addiction indices. Again, LDA identified robust bacterial differences 
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between groups. Plotting baseline samples identified using LDA on a Receiver Operating 
Characteristic (ROC) curve predicted whether a drug naïve animal would become a future low or 
high responder. This study is the first to report that microbiota variability reflects variability in 
cocaine intake and that the microbiota might be used as a diagnostic tool to predict the likelihood 
of future drug use. 
Note: Sierra Simpson, Giordano de Guglielmo, Jennysue Kasiah, Benjamin Anthony, Oliver 
George, Benoit Chassaing, and Kyle Frantz all contributed to the following experiments. 
4.2 Introduction 
Substance use disorder (SUD) affects more than 25 million Americans (Bercik et al., 
2010), leads to mental, physical, and behavioral deficits (NSDUH, et al. 2013) and yet continues 
without effective treatments (Fischer et al., 2015; Simpson et al., 1999). Despite the prevalence 
of SUD, only about 15-30% of individuals who initiate drug use develop chronic use habits and 
addiction (Wang et al., 2012b; Anthony et al., 1994; Saunders and Robinson, 2013; Franken et 
al., 2000). The factors that underlie addiction vulnerability are still poorly understood, 
stimulating continued investigation of novel approaches to treat and prevent drug abuse and drug 
relapse. 
The gut-brain axis is a bi-directional communication pathway between the 
gastrointestinal tract and the central nervous system (Martin et al., 2018), that is involved in 
several neuropsychiatric disorders (Kim and Shin, 2018), including substance use disorder 
(Meckel and Kiraly, 2019; Dinan and Cryan, 2017). The gut microbiota carries out metabolic 
functions, contributes to immune responsivity, produces molecules that signal locally, activates 
neuronal projections to the brain, and enters the bloodstream for distribution throughout the body 
(Cryan et al. 2012). Variability in microbial communities among subpopulations of humans and 
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other animals may contribute to individual differences in disease, symptomatology, and/or 
general behavioral characteristics, but the ability of microbial profiles to predict vulnerability to 
addiction has not been explored. 
The gut microbiota is different among individuals abusing alcohol (Engen et al., 2015a), 
opioids (Wang et al., 2018), or cocaine (Cho and Blaser, 2012; Volpe et al., 2014), compared 
with healthy controls, but whether the drugs induced the change or the distinct microbiome pre-
existed the drug use is not clear. Diet, stress, and other environmental or genetic factors could 
alter the gut microbiota (Karl et al., 2018; Lyu and Hsu, 2018; Wen and Duffy, 2017), increasing 
drug sensitivity. Alternatively, gut inflammation, reduced blood flow, and/or ulcers associated 
with drug use could be mechanisms through which drugs of abuse such as cocaine cause 
dysbiosis in the gut microbiome (Chievero et al 2019). With regard to opioid intake, gut 
microbial depletion via non-absorbable oral antibiotics results in widespread changes in neuronal 
ensembles that are activated by oxycodone intoxication and withdrawal. This suggests that the 
gut microbiome may play a role in opioid use and dependence (Simpson et al. 2020). In mice, 
antibiotic-induced gut dysbiosis is associated with elevations in cocaine reward, perhaps related 
to reduced production of short chain fatty acids (Kiraly et al., 2016), a concept supported by 
methamphetamine reward among rats as well (Ning et al., 2017). These reports and others drive 
continued exploration of the gut-brain axis in cocaine-related behaviors.  
The present study tested the hypothesis that drug use and microbiota composition are 
linked in such a way that microbiota profiles can predict susceptibility to drug use and that drug 
use can alter microbiota composition. Specifically, we predicted that the gut microbial 
communities characterized through fecal sample analysis would be different between addiction-
resistant and addiction-prone adult male rats, with addiction vulnerability defined by a battery of 
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cocaine-related behavioral tests including self-administration, escalation, compulsive drug-
seeking, and irritability. 
4.3 Materials and Methods 
4.3.1 Animals 
Male heterogenous stock (HS) rats were provided by Dr. Leah Solberg (Wake Forest 
University School of Medicine). Rats were housed two per cage on a reverse 12 hour/12 hour 
light/dark cycle (lights off at 8:00 AM) in a temperature (20–22°C)- and humidity (45–55%)-
controlled animal facility with ad libitum access to water and food. All experiments were 
designed to minimize animal suffering. All of the procedures were conducted in adherence to the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute 
and the University of California San Diego 
4.3.2 Drugs 
Cocaine HCl (National Institute on Drug Abuse, Bethesda, MD) was dissolved in 0.9% 
saline (Hospira, Lake Forest, IL) at a dose of 0.5 mg/kg/0.1 ml infusion and self-administered 
intravenously. 
4.3.3 Intravenous catheterization 
The animals were anesthetized by isoflurane inhalation, and intravenous catheters were 
aseptically inserted in the right jugular vein using a modified version of a procedure that was 
described previously (47, 48). The vein was punctured with a 22-gauge needle, and the tubing 
was inserted and secured inside the vein by tying the vein with suture thread. The catheter 
assembly consisted of an 18 cm length of Micro-Renathane tubing (0.023-inch inner diameter, 
0.037-inch outer diameter; Braintree Scientific, Braintree, MA, USA) that was attached to a 
97 
guide cannula (Plastics One, Roanoke, VA, USA). The guide cannula was bent at a near right 
angle, embedded in dental acrylic, and anchored with mesh (2 cm square). The catheter exited 
through a small incision on the back, and the base was sealed with a small plastic cap and metal 
cover cap. This design helped to keep the catheter base sterile and protected. The catheters were 
flushed daily with heparinized saline (10 U/ml of heparin sodium; American Pharmaceutical 
Partners, Schaumburg, IL, USA) in 0.9% bacteriostatic sodium chloride (Hospira, Lake Forest, 
IL, USA) that contained 20 mg/0.2 ml of the antibiotic Cefazolin (Hospira, Lake Forest, IL, 
USA). After recovery from surgery, rats were tested in several behavioral assays, per the 
experimental timeline (Figure 4.1). All behavioral testing was conducted during the dark phase. 
4.3.4 Operant training 
Self-administration was performed in operant chambers (Med Associates, St. Albans, VT, 
USA). Each chamber was equipped with two retractable levers. Cocaine was delivered through 
an infusion pump that was activated by responses on the right lever (active), resulting in the 
delivery of cocaine (0.5 mg/kg/0.1 ml). Responses on the left lever (inactive) were recorded but 
had no scheduled consequences. The rats were first trained to self-administer cocaine under a 
fixed-ratio 1 (FR1) schedule of reinforcement in daily 2-h sessions, for 10 days. A cue light was 
paired with each cocaine reward for 20-s. During this timeout (TO) period, lever presses were 
not followed by any cocaine infusion. After the completion of the short access period, the rats 
were subjected to daily 6-h long access (LgA) self-administration sessions to allow them to 
escalate their cocaine intake (Ahmed and Koob, 1998) over 14 days. 
4.3.5 Progressive Ratio 
At the end of the ShA and LgA phases, rats performed a progressive ratio test. The 
progressive ratio (PR) schedule of reinforcement was used to assess the break point, a valid 
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measure of the reinforcing value of a reward (Stafford et al., 1998; Hodos, 1961). Following 
acquisition of cocaine (10 sessions) the rats were also tested in a progressive ratio (PR) schedule 
of reinforcement. Under these conditions, the response requirements necessary to receive a single 
drug dose increased according to the equation: [5e (injection numbers x 0.2)] − 5. This resulted in the 
following progression of response requirements: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 
95, 118, 145, 178, 219, 268, etc. The breakpoint was defined as the last ratio attained by the rat 
prior to a 60 min period during which a ratio was not completed. The performance under 
progressive ratio was repeated two times after the LgA phase. 
4.3.6 Compulsivity- like behavior 
The day after the last extended access to cocaine self-administration and PR, the animals 
were placed in the self-administration chamber for a 1 h session, and they were tested for 
compulsive-like behavior. In this experiment, the rats were allowed to self-administer cocaine on 
an FR1 schedule of reinforcement, in which 30% of the reinforced responses were paired with a 
contingent footshock (0.1 mA, 0.5 s). After completion of this phase, the same procedure was 
used every 3 days, with the only difference that the intensity of the footshock was increased to 
0.2 mA, 0.5 s and 0.3mA, 0.5s. 
4.3.7 Feces collection 
At times marked in Figure. 1a, animals were held by the base of the tail so that the front 
paws were on a solid surface and the back paws are able to be lifted off the surface. The back 
paws were gently moved up and down off of the surface until a fresh fecal pellet was released. 
Immediately the feces were collected into a sterile tube and put on dry ice. Once all feces were 
collected, the tubes were moved to -80°C for storage, then shipped overnight to Georgia State 
University’s Neuroscience Institute for storage at -80°C until use. 
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4.3.8 Fecal microbiota analysis by 16S rRNA gene sequencing 
DNA was extracted from frozen feces using QIAamp 96 Powerfecal QIAcube HT Kit 
(Quiagen) with mechanical disruption (bead-beating). Fecal microbiota was analyzed as 
previously described (Chassaing et al., 2015). Briefly, the 16S rRNA genes, region V4, from 
each sample were PCR amplified using a composite reverse primer and a forward primer 
containing a unique 12-base barcode used to tag PCR products from respective samples. PCR 
products were purified with magnetic beads (Beckman Coulter), visualized by gel 
electrophoresis and quantified using Epoch Microplate Spectrophotometer (Biotek). A master 
DNA pool was generated and sequenced using a Illumina MiSeq (2*250 bp, paired end) 
sequencer at the Cornell University. 
4.3.9 Genetic sequence analysis  
16S rRNA gene sequence analysis was performed as previously described (Chassaing et 
al., 2015). Sequences were demultiplexed, quality filtered using the Quantitative Insights Into 
Microbial Ecology (QIIME) software package (Caporaso et al., 2012), and forward and reverse 
Illumina reads were joined using the fastq-join method (http://code.google.com/p/ea-utils) 
(Aronesty, 2013). QIIME default parameters were used for quality filtering and sequences were 
assigned to OTUs using the UCLUST algorithm (Edgar, 2010) with a 97% threshold of pairwise 
identity and classified taxonomically using the Greengenes reference database (McDonald et al., 
2012). Principal coordinate analysis of the unweighted UniFrac distances was used to assess the 
variation between samples (beta diversity) (Lozupone et al., 2011). Beta diversity was further 
visualized via jackknife-supported PCA plots. Alpha diversity and rarefaction curves were 
calculated and displayed using observed OTUs as the variable of interest. OTU sorting and 
100 
sequencing analysis has been previously validated and adapted from previous work in rats 
(Fields et al. 2018). 
4.3.10 Identification of bacteria predicting drug use 
Predictive analysis was conducted by generating Receiver Operating Characteristic (ROC 
Curves) and area under the curve (AUC), as adapted from (Sokol et al., 2019) using the new 
multiple logistical regression tool in updated Graphpad 8 PRISM (v 2019). In brief, regression 
plots of species relative abundance was plotted against bacteria present in sample (binary: 
yes/no). Artifacts due to phylogeny differences were discarded and present curves represent 
lowest similar taxonomic identification. ROC curve quality was assessed based on previous 
standards (Mandreka et al. 2010). Curves with AUC less than 0.5 were excluded from analysis. 
4.3.11 Statistics  
Statistics on behavioral outcomes, including median splits and z-score calculations were 
conducted with IBM SPSS v. 23, and corresponding behavior graphs were generated using 
PRISM 7/Graphpad software (San Diego, California, USA). ROC curves were generated using 
the latest plugin application in Prism/Graphpad (v.8.3.0). Generation of robust bacterial 
differences between groups, using Linear discriminant analysis Effect Size (LEfSe) was 
accomplished using the online Galaxy tool (http://huttenhower.sph.harvard.edu/galaxy/). Galaxy 
was also used to generate Linear discriminant analysis (LDA) bar charts and corresponding 
cladograms. Determination of predictive biomarkers was accomplished via a combination of 
LEfSe baseline output data, highly abundant taxonomic groups observed in the present samples, 
and from the literature on bacterial groups previously associated with substance use disorder or 
related conditions. Diversity plots and relative abundance stacked bar charts were generated via 
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QIIME. Differences in distinct clustering in PCA plots was assessed via PERMANOVA method 
using vegan R-package through QIIME. 
4.4 Results 
4.4.1 Identification of low- and high-vulnerability subpopulations based on 
variability in behavioral outcomes 
Rats self-administered cocaine under four different experimental conditions, per the 
timeline in Figure 4.1a. In each condition, variability in response rates allowed division of 
subjects into low vs. high responder subgroups, using a quartile split separately for each measure 
(Figure. 4.1 b) During short access self-administration (2 h/day, the number of cocaine infusions 
(rewards) earned per session was between 0 and 90, with an average of 6.13 +/- 6.17. The bottom 
25% of animals, labeled as low or resistant responders, had an average of 0.97 +/- 0.1 rewards 
earned per session. The top 25% of animals, labeled as high or vulnerable responders, had an 
average of 16.3 +/- 1.21 per session. The behavior split between all animals divided into quartiles 
is shown by session (Figure 4.1 a ) During long access/ escalation self-administration (6 h/day), 
cocaine infusions ranged from 0 to 277 with an average of 77.14 +/- 1.59. Low responders had 
an average of 27.13+/- 2.15 infusions per session whereas high responders had 121.8 +/- 2.05 
infusions per session. The behavior split between all animals divided into quartiles is shown by 
session (Figure e 4.1 b). During PR, we observed that all animals except for low responders had 
higher presses when PR was conducted after LgA compared to ShA (Figure 4.1 b). This trend 
was not observed in total active lever presses as only animals binned in the top 50% of 
responders had higher PR presses after LgA compared to Sha. In animals that were binned into 
the bottom 50% of responders PR did not different between session day. Low responder animals 
had an average 1.6+/- 0.33 reward infusions and 3.47 +/- 0.68 active lever presses during PR. 
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High responders had an average of 9.77 +/- 0.89 reward infusions and 49.7 +/- 7.39 active lever 
presses during PR. Under intermittent shock conditions, the number of cocaine infusions 
decreased as the shock intensity increased, but high vs. low responders were differentiated at 
each shock value (Figure 4.1 c). To summarize, distance from the mean for response groups were 
transformed into Z-scores on each measure (LgA, PR, and shock), and also were averaged to 
create an overall Addiction Index that averages individual rat scores on all three self-
administration conditions (Figure 4.2). The use of the top 25% (high, vulnerable) of subjects and 
the bottom 25% (low, resistant) of subjects based on the overall Addiction Index was used for 
microbiota comparisons. When examining the contribution of cohort to results we saw that there 
was high variability between groups of animals, a potential limitation to this study (Supplemental 
Figure. 4.1). Given the evidence that the microbiota and cocaine related behaviors have high 
variability, we wanted to eliminate cohort-specific effects through the use of multiple groups.  
4.4.2 Short-access cocaine self-administration induced modest alteration in the 
intestinal microbiota composition.  
To assess the impact of short cocaine self-administration sessions on the intestinal 
microbiota, we used the addiction index z-scores to divide subjects into low (Q1) and high (Q4) 
vulnerability groups and compared the microbiota composition from fecal samples take after 
short access test conditions. Overall microbial communities do not cluster into separate 
populations, i.e. beta diversity is not significantly different based on principal coordinates 
analysis (Figure. 4.3a). However, individual bacterial groups do vary in relative abundance, as 
demonstrated with LEfSe results plotted in a cladogram (Figure. 4.3 b) and bar chart (Supp. 
Figure 4.2 b). Specifically, the family Enterobacteriaceae, the order Enterobacteriales, the class  
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Figure 4.1 Behavioral testing timeline and behavioral outcomes 
 
a. The experimental timeline indicates the order of procedures carried out with all subjects. Fecal 
matter was collected at timepoints indicated by the arrows. Based on the number of cocaine 
infusions or behavior on the PR schedule, rats were divided into four quartiles each covering 
25% of the subjects (from low to high; green, yellow, orange, red). Panels show rewards earned 
under b. short-access conditions (2 h/day), c. long access (6 hr/day), d. PR schedule of 
reinforcement, e. or compulsive drug seeking in the face of intermittent footshock paired with 
cocaine infusions. 
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Figure 4.2 Highly variable cocaine behavior sorted into z-scores for microbial analysis 
The left three panels show individual z-score distributions for low and high responders on the 
long-access, PR, and compulsive (shock) conditions. The right panel shows an average of 
scoring on all three measures, creating an overall addiction index and plotting z-score 
distributions for low and high responders. All subjects self-administered cocaine under all 
conditions.  
 
Gammaproteobacteria, and the genus Anaerostipes are all more robustly expressed in the low 
responders vs the high responders at this time point, although none of these groups are found in 
particularly high levels in either addiction group (data not shown) No differences in alpha 
diversity after short access cocaine self-administration were seen in high vs low responders. 
(Supplemental Figure 4.2 b). 
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Figure 4.3 Impact of short-access cocaine self-administration on microbiota composition 
a. Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of the 
bottom quartile of cocaine resistant rats on the overall addiction index (Q1, red) and top quartile 
of cocaine vulnerable animals (Q4, blue), shows no significant clustering based on sequencing 
16s rRNA bacterial genes from fecal samples collected after short-access conditions. b. 
Taxonomic cladogram obtained from linear discriminant analysis effect size (LEfSe) highlights 
specific bacterial taxa that were relatively more abundant in Q1 (red) or more abundant in Q4 
(green). Minimum LEfSe score was 2.0. 
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4.4.3 Long-access cocaine self-administration induced gut microbiota dysbiosis 
To assess the impact of longer (6 hr/day) cocaine self-administration sessions on the 
intestinal microbiota, we used the addiction index z-scores to divide subjects into low (Q1) and 
high (Q4) vulnerability quartiles and compared the microbiota composition from fecal samples 
taken after long access test conditions. Overall microbial communities clustered into distinct 
populations, as determined by PCoA of the unweighted UniFrac distance matrix (Figure. 4.4 a). 
Moreover, individual bacterial groups varied in relative abundance, as demonstrated with LEfSe 
results plotted in a cladogram (Figure 4.4 b) and bar chart (Supplemental Figure 4.3). 
Specifically, the class Erysipeltotrichi, the order Erysipetotrichales the families 
Erysipelotrichaceae and Bacteroidaceae and the genus Allobacullum were all more robustly 
expressed in the high responders vs low responders at this time point, although none of these 
groups is found in particularly high levels in either addiction group (data not shown). On the 
other hand, drug resistant animals showed relatively higher abundance of the family 
Eubacteriacease and the genus Anaerofustis. Among these, only the phylum Bacteroidetes was 
identified at high proportions in the samples (Supplemental Figure 4.3 b). No differences in 
alpha diversity after short access cocaine self-administration were seen in high vs low 
responders. (Supplemental Figure 4.3 a).  
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Figure 4.4 Impact of long-access cocaine self-administration on microbiota composition 
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a. Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of the 
bottom quartile of cocaine resistant rats on the overall addiction index (Q1, red) and top quartile 
of cocaine vulnerable animals (Q4, blue), shows differential clustering based on sequencing 16s 
rRNA bacterial genes from fecal samples collected after these long-access conditions (p=0.017). 
b. Taxonomic cladogram obtained from LEfSe highlights specific taxa that were relatively more 
abundant in Q1 (red) or more abundant in Q4 (green). Minimum LEfSe score was 2.0. 
 
In addition to using the addiction index z-scores, we also used the long-access 
(escalation) z-scores to subdivide animals for consideration of the impact of long-access cocaine 
self-administration on microbial profiles. With this differentiation, we again observed a 
significant difference in beta diversity between high and low responders (Figure 4.5 a). Overlap 
in bacterial subpopulations showing greater relative abundance in high responders was observed: 
family Clostridiaceae, Erysipilotrichaceae, family Peptostreptococcaceae, genus Allobaculum, 
genus SMG53, and order Erysipelotrichales.  
In addition, several groups showed higher relative abundance in high responders with this 
z-score but not the prior: family Elulsimicrobiaceae, family Turicibacteraceae, family 
Bifidobacteriaceae, genus Bifidobacterium, genus Ruicibacter, order Bifidobacteriales, order 
Elusimicriobiales, and order Turicibacterales. Conversely, several groups showed higher relative 
abundance in the low responders: family Verrucomicrobiaceae, genus Ruminococcus, genus 
Akkermansia, genus Oscillospire, order Verrucomicrobiales, and order YS 2. Using the 
escalation index as the determining factor for cocaine vulnerability resulted in no differences in 
alpha diversity (supplemental figure 4.4 a). Individual bacterial contributions to microbial 
profiles are detailed in supplementary materials through LEfSe (Supplemental Figure 4.4 a) and 
the overall abundance charts show that some phylum levels are shifted between high and low 
responders. (Supplemental Figure 4.4 c). 
109 
 
 
 
Figure 4.5 Impact of long-access cocaine self-administration on microbiota composition, 
with subpopulations defined by long-access (escalation) z-score 
a. Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of the 
bottom quartile of cocaine resistant rats on the specific escalation z-score (Q1, red) and top 
quartile of cocaine vulnerable animals on the escalation z-score (Q4, blue), shows differential 
clustering based on sequencing 16s rRNA bacterial genes from fecal samples collected after 
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these long-access conditions (p=.001). b. Taxonomic cladogram obtained from LEfSe highlights 
specific taxa that were relatively more abundant in Q1 (red) or more abundant in Q4 (green). 
Minimum LEfSe score was 2.0. 
 
4.4.4 Microbial composition may predict future cocaine use 
As noted in the timeline (Figure 4.1 a), fecal samples were also collected before any 
exposure to cocaine. Microbiota composition analysis in these samples demonstrated that before 
cocaine exposure, microbiota profile does not cluster differentially based on the likelihood of 
cocaine use later in life, as presented Figure 4.6 when using the Total addiction z-score. 
However, when looking at individual taxa contribution to future phenotypes via LeFSe analysis 
(Supplemental Figure 4.5 b) and taxa summarization (Supplemental Figure 4.5 c), we observed 
that certain bacterial groups were significantly altered in future high versus low cocaine 
responders. Specifically, Akkermansia muciniphila was more highly represented in future low 
responders versus future high responders. Conversely, the orders Anaeroplasmatales and 
Turcibacterales, families Ruminococcaceae, Anaeroplasmataceae, and Turicbacteracae, genera 
Ruminococcus, Aneroplasma, Allobaculum and Turicbacter were all more robustly expressed in 
future high responders vs future low responders (Figure 4.6 and Supplemental Figure. 4.5a). 
Some of these clades belong to phyla that are among the most highly abundant in both low and 
high responders (Actinobacteria, Firmicutes, Tenericutes, and Verrucomicrobia; Supplemental 
Figure 4.5c). Moreover, future high responders have higher alpha diversity compared to future 
low responders (Figure 4.6 and Supplemental Figure 4.5a).  
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Figure 4.6 Using the microbiome to predict future cocaine sensitivity 
a. Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of the 
bottom quartile of cocaine resistant rats on defined by the overall addiction index (Q1, red) and 
top quartile of cocaine vulnerable animals on the addiction index (Q4, blue) does not show 
differential clustering based on sequencing 16s rRNA bacterial genes from fecal samples 
collected before any cocaine exposure (baseline samples). b. Taxonomic cladogram obtained 
from linear discriminant analysis effect size analysis of fecal 16S ribosomal RNA genes 
sequencing. Animals that go on to show high sensitivity to cocaine reward and reinforcement 
have certain bacteria more represented compared to animals that go on to be low responders. 
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Taxonomic cladogram obtained from LEfSe highlights specific taxa that were relatively more 
abundant in Q1 resistant (red) or more abundant in Q4 vulnerable (green) subpopulations, even 
before any cocaine exposure. Minimum LEfSe score was 2.0. 
 
 
Using output from the LEfSe, we chose two clades to test as potential biomarkers that 
might discriminate future membership in the high vs. low responder quartiles, based on the 
overall addiction index. The ROC curve plotting rates of true positive (sensitivity) against false 
positive (specificity) revealed that higher abundance of the species Akkermansia muciniphila 
showed excellent predictive value for membership in the low responder group (AUC=.8103), 
whereas the family Ruminococcaceae discriminated high responsivity (AUC=0.7388; Figure 
4.7).  
Based on relevant literature linking the phyla Firmicutes and Bacteroidetes (or the ratio 
of their relative abundance) with obesity (John and Mullin, 2016), age (Mariat et al., 2009), and 
alcohol use disorder (Engen et al., 2015a), we also plotted ROC curves for these clades. 
Firmicutes and Bacteroidetes separately showed only fair discrimination of future cocaine 
sensitivity with AUCs of 0.6429 (Supplemental Figure 4.6a) and 0.6027 (Figure 4.6b), 
respectively. Similarly, the ratio of the two yielded modest predictive results (AUC=0.625; 
Supplemental Figure 4.6c). 
Evidence suggests that the genus Lactobacillus, part of the order of Lactobacillaceae are 
an important bacteria in psychological and social health and well-being. Specifically in rodents, 
administration of probiotics containing Lactobacillus reverses damage that psychological stress 
has on the brain (Ait-Belgnaoui et al., 2013) as well as moderate psychological stress 
responsivity (Messaoudi et al., 2010; Messaoudi et al., 2011). Since there is several lines of 
evidence that addiction phenotypes are highly comorbid with other neuropsychiatric conditions 
such as exaggerated stress responsivity (Regier et al., 1990) and that several neuropsychiatric 
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conditions are related to the gut microbiota (MacQueen et al., 2017), we sought to examine 
whether Lactobacillus related bacteria at baseline could predict future drug use. ROC curves 
revealed that the order Lactobacillaceae showed fair discrimination (AUC=0.6897; 
Supplemental Figure 4.7a), while the genus Lactobacillus was a poor predictor (AUC=0.6272; 
Supplemental Figure 4.7b).  
 
 
 
Figure 4.7 Specific taxa predict future cocaine sensitivity 
a. Specific microbial signatures were analyzed from fecal samples obtained at baseline before 
any cocaine exposure, using a random forest algorithm to predict future phenotype contribution. 
The species Akkermansia muciniphila (AUC=0.8103) and family Ruminococcaceae 
(AUC=0.7388) both had strong probability of predicting future addiction index phenotype 
 
4.5 Discussion 
Cocaine use is a debilitating condition that is estimated to affect millions of people in the 
united states per year (Pomara et al., 2012). Despite the chronic strain cocaine use and use of 
other illicit substances has on the population, uncovering effective therapeutics has been difficult 
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in part due to the high variability of intake by individuals both in rodents (Panlilio et al., 2003) 
and humans (Davidson et al., 1993). With several lines of evidence that cocaine seeking behavior 
and the microbiota are intertwined (Kiraly et al., 2016; Meckel and Kiraly, 2019; Chivero et al., 
2019; Cryan et al., 2019) we sought to determine the relationship between microbiota profile and 
cocaine responsivity as well as ascertain whether the microbiota could be a useful diagnostic tool 
to predict severity of future cocaine use. 
The gut microbial communities in low vs. high addiction-prone rats in the present study 
were different in ways that not only reflect acute and long-term impact of cocaine intake on 
bacterial populations but also predict membership in the low or high sensitivity subgroup. For 
example, while short-access (2 hr/day) to cocaine self-administration was associated with higher 
relative abundance of a few bacterial subgroups in low vs. high responders, it was the long-
access escalation conditions (6 hr/day) that reduced the overall bacterial diversity in the high 
responder group and also clearly differentiated the bacterial communities, with more than 15 
specific taxa showing significant elevations or declines in one population or the other. Baseline 
sampling prior to cocaine exposure also revealed some potential biomarkers for cocaine 
resilience or sensitivity.  
 The behavioral and microbial assays used in this study have been validated previously 
and are highly relevant to evaluate addiction-like behaviors and microbial composition 
(Chassaing et al 2012). Rats were tested in a battery of behavioral assays using standard 
operating protocols that measure different aspects of the reinforcing effects of cocaine. The level 
of responding for cocaine under a fixed ratio schedule of reinforcement after short vs. long 
access has been shown to be highly relevant to model the difference between recreational drug 
use and drug addiction (Ahmed et al. 1998; George et al. 2014) The progressive ratio (PR) 
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schedule of reinforcement was used to assess the break point, a valid measure of the motivation 
to seek a reward (Stafford et al 1998; Hodos et al. 1961) The resistance to contingent foot shock 
has been established as a relevant measure to evaluate compulsive-like responding for drugs 
(Vanderschuren et al. 2004; Deroche-Gamonet et al. 2004).  
Quartile splits in behavioral outcomes were used successfully to show low- and high-
responding subgroups for short-access cocaine self-administration (2 hr/day), long-access self-
administration (6 hr/day), motivation to seek cocaine on a PR schedule of reinforcement, and 
compulsive cocaine-seeking despite concurrent footshock. Both raw values and variability in 
cocaine-related behaviors were consistent with prior reports (Briand et al. 2008; George et al. 
2008; Verheij et al. 2018), supporting the reliability and validity of the behavioral outcomes. In 
addition, microbiome profiling revealed levels of beta diversity and alpha diversity, as well as 
dominant bacterial taxa, that are similar to those reported in other studies of rodents (Li et a. 
2017) and share similarity with clinical reports on human participants (Human microbiome 
consortium, 2012). Thus, the description of microbial communities within and between the 
subsets of rats categorized as low and high addiction-prone is based on reliable microbiome 
profiling.  
The impact of relatively low-level cocaine intake was assessed using fecal samples 
collected after the short-access phase of cocaine self-administration. Although the overall 
microbiota diversity and richness was not altered between animals that fell into the lowest vs. 
highest quartiles of the overall addiction index, some interesting individual differences in relative 
abundance suggest the possibility that bacterial communities in low responders contained higher 
levels of some beneficial bacterial taxa. For example, the family Enterobacteriaceae is abundant 
in the gut of newborn and juvenile mammals (Bokulich et al., 2016), perhaps suggesting a role in 
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growth and development, while the overall class of Gammaproteobacteria, to which 
Enterobacteriaceae belong, is elevated after gastric surgery in both humans (Aron-Wisnewsky et 
al. 2014) and rodents (Antonelli et al. 2009), suggesting a role in recovery. Both of these taxa 
were more abundant in cocaine-resistant animals in the present study. Anaerostipes is among the 
many bacterial taxa known to produce short chain fatty acids (Schwertz et al. 2002; Duncan et al. 
2004). Its higher abundance in low responders could support prior reports that exogenous SCFA 
administration reduces cocaine’s reward value in mice (Kiraly et al. 2016).  
In contrast to results observed after short-access cocaine self-administration, we observed 
more robust differences in gut bacterial communities between low and high responding animals 
after the long-access phase of self-administration, whether the low and high quartiles were 
defined using the overall addiction index or the specific escalation index that takes into account 
only the degree of escalation under long-access conditions. Alpha diversity within the sample 
populations was not different using either z-score subdivision, but beta diversity was 
significantly different in each case, suggesting that high cocaine intake during the escalation 
model creates a distinct microbial environment in the gut. With regard to specific taxonomic 
groups, the two taxa that were overrepresented in the guts of low vs. high responders after short-
access cocaine were no longer elevated after long-access. Yet Anaerofustis was, and it is also a 
SCFA producer of the family Eubacteriaceae in the class Clostridia (Duncan et al. 2007; Poeker 
et al. 2018). When categorizing rats based on the escalation index alone, two additional clades 
from the class Clostridia were higher among low responders: Oscillospira, which is associated 
with gastric dysfunction (Lam et al. 2012) and Ruminococcus gnavus, which is associated with 
low oxygen conditions and gut inflammation (Henke et al. 2019). Notably, several Clostridia 
species were also higher among non-opioid users, compared with opioid abuse patients (Acharya 
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et al., 2017). Finally, Akkermansia muciniphila was higher among low responders at this time 
point, and this is a species well known for its inverse relationship with cardiometabolic disease 
and gut inflammation (Cani et al. 2017 ;Naito et al. 2018). As the name implies, A. muciniphila 
is associated with integrity of the intestinal mucosal barrier, including immune system function 
as well as the production of SCFA (van Passel et al. 2011). A. Muciniphila has high relative 
abundance among non-obese, healthy controls (Xu et al. 2020, Dao et al. 2016) and those on 
ketogenic diets (Olson et al. 2018), for example. Therapeutically, chronic alcohol consumption 
lowers relative abundance of A. muciniphila and administration of A. muciniphila to patients 
with alcoholic liver disease ameliorates their symptoms (Grander et al. 2018). It is also shown 
that A. Muciniphila, and subsequently higher levels of SCFAs, are prevalent in rats that consume 
coffee (Gao et al. 2018). 
Regardless of whether the overall addiction index or the escalation index was used to 
subdivide rats, the highest quartile of cocaine responders showed higher relative abundance of 
two different clades within the class Clostridia:, SMB53 and Peptostreptococcaceae, along with 
the genus Allobaculum from the class Erysipelotrichia. Interestingly, both methamphetamine and 
cocaine users also show higher relative abundance of Allobaculum, compared with healthy 
controls (Franzosa et al., 2019; Scorza et al., 2019). Moving on to those clades associated with 
high responders defined by the escalation index, three taxa might be explored for their specific 
relationship with higher doses of cocaine intake: Elusicrobiaceae, Turcibacter, and 
Bifidobacterium. A different set of clades differentiated high responders when defined using the 
overall addiction index including F16, Alcaligenaceae, Sutterella, and Bacteroides. Notably, the 
relative abundance of taxa in the phylum Bacteriodetes (which includes Bacteroides) predicted 
cocaine use in humans (Volpe et al., 2014) and is higher among alcohol users compared to non-
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user controls (Volpe et al., 2014) (Fan et al., 2018), as well as rodents given chronic alcohol 
(Yan et al. 2012). Overall, the impact of these changes in the gut depends on the specific 
functionality provided by the clades independently, as well as their influence on one another in 
the bacterial communities of the gut. Furthermore, whether or not these changes in bacterial 
populations are responses for cocaine intake and irritability tests or causes of the differences in 
responsivity on these tests remains to be determined. One approach in beginning to understand 
these distinctions is to investigate which clades were already highly abundant in low vs. high 
responders at baseline before cocaine intake.  
Among the most promising translational components of this study is the potential to 
identify biomarkers of cocaine vulnerability. Thus, the bacterial taxa that were higher at baseline 
among future low responders could be protective, whereas the taxa that were higher among 
future high responders could be associated with vulnerability. The most interesting of these 
might be Akkermansia muciniphila, which was higher at baseline among future low responders. 
Not only that, it remained higher among low responders throughout long-access testing. Further 
statistical exploration using the ROC curve suggested this species as an excellent predictor of 
belonging in the low addiction prone subpopulation. Conversely, perhaps playing a role in 
vulnerability are the Allobaculum and Turcibacter populations that were higher among high 
responders at baseline and after long-access testing. The genus Anaeroplasma was also higher at 
baseline among future high responders, warranting further investigation. Interestingly, the genus 
Ruminococcus was higher in high responders at baseline, but the Ruminococcus gnavus species 
was higher in low responders later in the experiment, suggesting that its decline relative to other 
taxa could be an important factor in the behavioral switch to high response levels. Nevertheless, 
the Ruminococcaceae family was a strong predictor of membership in the high addiction prone 
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subpopulation, according to the ROC analysis. This family has been associated with drug reward, 
impulsivity, attention, and locomotor activation in animal models (Ning et al. 2017, Peterson et 
al. 2020), as well as obesity and Alzheimer’s Disease in humans (Crescenzo et al. 2017, Zhuang 
et al. 2018, Ticinesei et al. 2018), although it is a SCFA producer (Jiang et al. 2015; Acharya et 
al. 2017), appeared lower in opioid users compared to healthy controls (Acharya et al., 2017), 
high abundance during abstinence from alcohol (Starkel et al. 2016), and was inversely related to 
cirrhosis (Ticinesi et al. 2018). The present results did not support the use of Lactobacillus as a 
predictor, nor Firmicutes, Bacteroidetes, nor the Firmicutes/Bacteroidetes ratio, per low 
discrimination ability in the ROC curve analysis.  
The mechanisms through which cocaine alters the gut microbiome remain to be 
determined. General perturbations to gut function have long been associated with cocaine use 
and abuse (Brown et al., 1994; Gibbons et al., 2009). Cocaine in mice issues proinflammatory 
responses and compromises the mucosal lining of the gut, along with changes in microbiota 
composition (Chivero et al., 2019). As a sympathomimetic drug, cocaine also activates alpha-
adrenergic receptors in the mesentery, leading to gastric ulcers and perforations in the gut 
membrane (Gourgoutis et al. 1994). Cocaine also exerts major impact to reduce blood flow to the 
gut, disrupt healthy diet, and disrupt exercise patterns (Cregler et al. 1986; Gibbons et al., 2009), 
each of which also affects the gut microbiota (Luna and Foster, 2015; Maslowski et al. 2011; 
Sandhu et al., 2017; Kang et al., 2014; Allen et al., 2015; Tang et al., 2017). These changes in the 
gut milieu are likely to favor certain bacterial populations while inhibiting the growth of others.  
Although this is among the first reports to characterize the impact of cocaine on the gut 
microbiota while also suggesting diagnostic tools to predict the likelihood drug vulnerability, 
several limitations are noted in this work. First, microbial profiling from fecal samples rather 
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than colon tissue restricts the view of the actual microbial environment in the gut (Stanley et al., 
2015). Second, the present animal subjects were tested in three cohorts, which showed baseline 
differences in the microbiome, but were combined for all analyses. Cohort effects and 
differences across populations of clinical and animal study participants call into question the 
generalizability of the identification of specific bacterial groups in correlation with disease 
and/or behavioral outcomes. Finally, as noted above, the mechanistic relationships between gut 
microbes and reward-related behaviors remain to be explored.  
In summary, several lines of evidence suggested that cocaine-seeking may be influenced 
by the gut-brain axis (Kiraly et al., 2016; Meckel and Kiraly, 2019; Chivero et al., 2019; Cryan et 
al., 2019) and the present work extends this concept by identifying microbial populations that are 
associated with specific phases of cocaine experience, including candidate biomarkers of cocaine 
resilience or vulnerability. Given that only a subset of cocaine-experienced individuals proceed 
to develop substance use disorder (McLellan, 2017), predictive gut profiles could suggest new 
treatment approaches to identifying addiction-prone populations. Pre- and probiotic formulas that 
promote the growth of bacterial species associated with low cocaine vulnerability may ultimately 
serve as effective adjunct therapies to treat addiction. 
4.6 Supplemental Figures 
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Supplemental figure 4.1.1: Comparison of microbiota diversity between cohorts 
Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of all fecal 
samples taken for this experiment by cohort (red= cohort 1, blue= cohort 2, gold= cohort 3). 
Given that these animals were outbred it comes as no surprise that microbiome composition 
varies between groups. 
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Supplemental Figure 4.2:  Characterization of microbiota after short access cocaine self-
administration correlates with drug seeking phenotype 
a. α-diversity in fecal samples after short access cocaine self-administration looking at observed 
OTUs. b. Linear discriminant analysis effect size was used to investigate whether individual 
bacterial taxa were more robustly represented in low vs high cocaine responders c. Taxa 
summarization performed at the phylum level in animals after short access self-administration. 
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Supplemental Figure 4.3:  Characterization of microbiota after long access cocaine self-
administration correlates with drug seeking phenotype 
a. α-diversity in fecal samples after long access cocaine self-administration looking at observed 
OTUs. b. Linear discriminant analysis effect size was used to investigate whether individual 
bacterial taxa were more robustly represented in low vs high cocaine responders after prolonged 
cocaine exposure. c. Taxa summarization performed at the phylum level in animals after long 
access self-administration.  
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Supplemental Figure 4.4:  Characterization of microbiota after long access cocaine self-
administration correlates with drug seeking phenotype when using different measures of 
behavioral dependent measures. 
 a. α-diversity in fecal samples after long access cocaine self-administration when using the 
escalation index as a measure of cocaine resistance or vulnerability. b. Linear discriminant 
analysis effect size was used to investigate whether individual bacterial taxa were more robustly 
represented in low vs high cocaine responders after prolonged cocaine exposure using the 
escalation index to discriminate cocaine seeking. c. Taxa summarization performed at the 
phylum level in animals after long access self-administration using the escalation index to 
discriminate cocaine seeking. 
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Supplemental Figure 4.5:  Characterization of microbiota at baseline predicts future cocaine 
phenotypes 
a. α-diversity in fecal samples at baseline looking at observed OTUs. b. Linear discriminant 
analysis effect size was used to investigate bacterial members that drive differences animals that 
become high and low cocaine responders. Individual bacteria groups appear responsible for 
future drug taking phenotype. c. Taxa summarization performed at the phylum level. At baseline 
there is a shift in relative phylum abundance between animals that become low cocaine 
responders and high cocaine responders. 
 
 
Supplemental Figure 4.6:  Using bacterial taxa associated with obesity and gut related disorders 
to predict future drug use. 
Receiver operator curve (ROC curve) showed that a. the phyla Firmicutes (AUC=0.6429) b. and 
Bacteriodetes (AUC=0.6027) did a poor job predicting future drug taking phenotypes. c. The 
ratio of these two phyla, which has previously shown to be associated with gastrointestinal 
disorders, including obesity, also was poor at predicting future drug taking behavior 
(AUC=0.625). 
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Supplemental Figure 4.7:  Using bacterial taxa associated with neuropsychiatric disease to 
predict future drug use. 
Receiver operator curve (ROC curve) showed that a. the order Lactobacillales (AUC=0.6897) b. 
and genus Lactobacillus (AUC=0.6272) did a fair/poor job predicting future drug taking 
phenotypes. These bacterial taxa have previously been associated with neuropsychiatric 
conditions such as depression, anxiety, and schizophrenia. 
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5 MODULATION OF THE GUT MICROBIOTA BY ANTIBIOTICS AND 
PROBIOTICS ALTERS COCAINE-SEEKING AFTER ABSINENCE IN 
ADOLESCENT AND ADULT MALE RATS 
5.1 Abstract 
Research on the gut-brain axis has revealed that gut dysbiosis is associated with several 
psychiatric disorders including substance abuse. We hypothesize that adolescent vulnerability to 
drug-related reward and reinforcement might also be related to gut dysbiosis. Using a cocktail of 
antibiotics in the drinking water of Wistar rats, we sought to determine whether reduced 
abundance of bacteria in the gut heightens intravenous cocaine self-administration. Moreover, 
probiotics appear to exert beneficial effects in the context of psychiatric disorders and the 
possibility exists that probiotic administration may reverse antibiotic-induced gut microbial 
depletion, restoring normal cocaine-related behaviors. Thus, a subset of rats received a 
commercial probiotic preparation (Probio’ Stick) via syringe feeding during a recess from 
cocaine self-administration. Adolescent and adult male rats were given two weeks of antibiotic 
exposure, fecal samples were collected, DNA was extracted, and qPCR was conducted to assess 
changes gut bacterial abundance. Simultaneously, animals acquired lever-pressing in operant 
conditioning chambers using a white noise training procedure, followed by cocaine self-
administration (0.37 mg/kg per infusion) on a fixed ratio 1 schedule of reinforcement for 8 
sessions, 2-hr each, over 10 days. Following 30 days of forced abstinence, animals underwent 
extinction and cue-induced reinstatement testing. A separate subgroup was tested on a 
progressive ratio (PR) schedule of reinforcement for two sessions after the 8 FR sessions. At 
sacrifice, peripheral organs were extracted to investigate gross anatomy and gut inflammation. 
Body mass and water intake were normal across treatment groups. Gut depletion was similar in 
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both age groups but adolescents and not adults recovered to baseline abundance levels after a 
thirty day recovery period. Cecum mass and size were greater in all antibiotic-treated animals, 
compared to age-matched controls, and a further increase was associated with cocaine intake in 
adults but not adolescents. No elevation in markers of inflammation was observed. Probiotics 
tended to restore normal cecum mass. Although gut dysbiosis did not alter cocaine self-
administration on fixed or progressive ratio schedules of reinforcement, it did increase 
reinstatement responding in adults but not adolescent-onset groups. Probiotics during abstinence 
restored reinstatement to baseline levels in adults but not adolescents. Additional 16S rRNA 
sequencing of bacterial genes from fecal samples allowed bioinformatic analysis of gut bacterial 
communities across treatment groups and time, demonstrating that antibiotic consumption and 
cocaine administration altered microbiota diversity in an age dependent manner. Together these 
results suggest that gut dysbiosis may be a factor in addiction vulnerability and that probiotics 
warrant investigation as adjunctive therapies especially in adult patients.   
Note: Brett Daniel, Jillian Dawson, Jennysue Kasiah, Natalie Brock, Benjamin Anthony, Sami 
Hatcher, Bonnie Williams, Benoit Chassaing, and Kyle Frantz all contributed to these 
experiments. 
5.2 Introduction 
Substance abuse is a major problem in the United States, with over 25 million Americans 
using illicit substances each month (SAHMSA, 2016) It is estimated that over 600 billion dollars 
per year goes towards the treatment and cost of drug addiction (Chung et al. 2006). One main 
issue in tackling these challenges is a long-lasting vulnerability to relapse that can persist years 
after abstinence has begun (Cregler and Mark, 1986). Cocaine in particular is the second most 
abused illicit substance behind marijuana (Quality, 2015). To date, therapies for treating cocaine 
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addiction and attenuating likelihood of cocaine relapse are generally ineffective (Indave et al., 
2016). 
Recent evidence suggests that changes in the human gut environment can influence 
diseases of the central nervous system (CNS) (Cryan and Dinan, 2012). The gut microbiome is a 
collection of bacteria, fungi, viruses, and protists that inhabit the gastrointestinal tract in 
commensal, symbiotic, or pathogenic relationships with their host and comprise substantial 
populations, with trillions of individual organisms (Turnbaugh et al., 2007; Bäckhed et al., 2005; 
Gill et al. 2006). Gut dysbiosis, defined as loss of overall microbial diversity, expansion of 
harmful microorganisms, and/or loss of beneficial microbes that combat the severity and 
prevalence of disease (Petersen and Round, 2014) has been implicated in many gastrointestinal 
diseases, including inflammatory bowel disease (Dalal et al. 2014; Devkota et al. 2013), Crohn’s 
disease (Khanna et al. 2017; Zuo et al. 2018), obesity (Sun et al. 2018; Wolf et al. 2012), and 
diabetes (Aw et al. 2018; Burcelin et al. 2011). With regard to CNS diseases and dysfunction, 
individuals with bi-polar disorder have distinct microbial populations compared to healthy 
controls (Jiang et al., 2015). Multiple sclerosis patients show altered microbiome diversity and 
react differently to probiotics compared to healthy controls (Tankou et al. 2018; Jangi et al. 
2016). Those with Alzheimer’s disease show shifts in microbiota functionalities (Vogt et al., 
2017). Moreover, patients with Autism Spectrum Disorder (ASD) take more antibiotics, have 
altered microbiota diversity, report more abdominal pain and irregular bowel movements, and 
show increased intestinal permeability and lower short chain fatty acid (SCFA) levels, compared 
to healthy controls (Wang et al., 2012; Ludvigsson et al., 2013; Yassour et al., 2016). Finally, 
patients diagnosed with schizophrenia have higher relative abundance levels of Lactobacillus 
bacteria compared to controls (Castro-Nallar et al. 2015; Yolken et al. 2015). 
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 In animal models of psychiatric conditions, mice show greater levels of anxiety- and 
depression-like behaviors after rearing in germ-free conditions (Bercik et al., 2011), along with 
altered microbial diversity, motor activity, and inflammatory cytokine profiles, compared to 
conventionally colonized mice (S. Simpson, 2018; Diaz Heijtz et al., 2011; Bercik et al., 2010). 
Restoration of a compromised gut microbiome via probiotics results in less depressive 
phenotypes in a mouse model of depression (Desbonnet et al. 2010). These studies and others 
support a role for bidirectional communication between the gut and brain, i.e. the “gut-brain 
axis” in neurological and mental disorders (Dinan and Cryan, 2017).  
Due in part to the high comorbidity between neuropsychiatric disorders and Substance 
Use Disorder (SUD) (Regier, 1990; Thaipisuttikul et al. 2014; Ross et al. 2012; Kelly et al. 
2013), the gut-brain axis has recently been implicated in SUD. Both clinical and animal studies 
in this nascent field support this concept. Chronic cocaine users have distinct microbial 
populations compared to healthy controls (Volpe et al., 2014), while heroin, methamphetamine, 
and/or ephedrine users show altered functional diversity of their microbiota compared to healthy 
controls, with underrepresentation of microbes likely to regulate cellular processes and signaling, 
as well as metabolism (Xu et al., 2017). Mice given a cocktail of non-absorbable antibiotics in 
drinking water had higher sensitivity to cocaine conditioned place preference than controls, an 
effect ameliorated with exogenous administration of a cocktail of SCFAs (Kiraly et al., 2016). 
Rats that developed methamphetamine conditioned place preference showed increased 
microbiota diversity compared to methamphetamine-naïve controls (Ning et al., 2017), along 
with a decrease in bacterial taxa responsible for synthesis of the SCFA propionate and less 
propionate in fecal samples. Propionate and other SCFAs are produced via metabolic 
fermentation of the diet by the microbiota (Stilling et al., 2016) and play critical roles in 
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neurological disease (Koh et al., 2016). Despite this clear evidence that drug reward is associated 
with gut microbial function, intravenous (i.v.) cocaine self-administration and subsequent 
extinction and reinstatement of cocaine-seeking after abstinence remain unexplored. The present 
study addressed this gap by allowing male rats to self-administer cocaine while receiving 
antibiotics in the drinking water, then testing extinction responding and cue-induced 
reinstatement of cocaine-seeking after 30 days of recess from both antibiotics and cocaine. We 
predicted that antibiotic treatment would decrease the abundance of gut microbes and increase 
the reinforcing effects of cocaine and/or cocaine-related cues.  
While antibiotics are used medicinally to treat pathogenic bacteria and experimentally to 
induce gut dysbiosis, probiotics are live microorganisms intended to have health benefits when 
consumed (Ciorba et al. 2012). Probiotic treatments might relieve symptoms of neuropsychiatric 
disorders (Cenit et al. 2017, Scriven et al. 2018). They reduce depressive-like behaviors in mice 
(Desbonnet et al. 2010) and depression symptoms and psychological outcomes in humans 
(Paineau et al. 2008; Girard et al. 2009; Messaoudi et al. 2010; Kazemi et al. 2018). Research 
investigating probiotic cocktails as a possible therapy for schizophrenia is already underway 
(Dickerson et al. 2014). The present experiment extended this work to test the hypothesis that 
probiotic treatment during a 30-day drug recess would restore normal (lower) levels of extinction 
and/or reinstatement responding in rats that had received antibiotics before and during cocaine 
self-administration.  
Adolescence is a transitional life-stage, marked by vast changes in neuronal circuitry 
(Pattwell et al., 2016) and often associated with high risk-taking behavior and experimentation 
with drugs of abuse (Poudel and Gautam, 2017). Most adult drug addicts report adolescent-onset 
of drug use (Prescott and Kendler, 1999; Brown et al., 2004; Patton et al., 2004). Yet, in our 
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laboratory, adolescent male rats reinstate less to drug seeking after abstinence, compared to adult 
counterparts (Li et al. 2009, Doherty et al. 2012, Doherty et al. 2013), suggesting that 
adolescence may be associated with resistance to some enduring effects of drugs, including 
cocaine, morphine, and heroin. Similarly, perturbations to the microbiome in early life are 
associated with behavioral alterations in adulthood (Rodríguez et al. 2015), effects attributed to a 
highly dynamic gut environment during adolescence (Borre et al.2014; Greenhalgh et al., 2016; 
Hollister et al., 2015), but direct comparisons between adolescent and adult perturbations in 
microbial communities are lacking. Therefore, this study included adolescent-onset age groups 
of male rats in explorations of both antibiotic and probiotic effects on cocaine-related behaviors. 
We predicted that adolescents are resistant to perturbations in the microbiota and to associated 
changes in drug-seeking behavior, compared with adult counterparts. 
5.3 Materials and Methods  
5.3.1 Subjects 
Adolescent and adult male rats (Charles River Laboratories, Inc, Raleigh, NC, USA) 
arrived at Georgia State University’s animal housing facility at postnatal day (PND) 22 and 70-
74, respectively. Animals acclimated to pair-housing in humidity and temperature-controlled 
ACS cages (Optirat Gen II by Animal Care Systems; Centennial, CO) on a reverse light cycle 
(12:12 hr, lights on at 19:00 hr) for three days prior to catheter surgery. Animals were given ad 
libitum access to food in water while in the home cage, except as described below for antibiotic 
treatments, were assessed daily for general health, and weighed periodically. All procedures 
were conducted in adherence to the Principles of Laboratory Animal Care and the National 
Institute of Health Guide for the Care and Use of Laboratory Animals (8th edition, 2011) and 
approved by Georgia State University’s Institutional Animal Care and Use Committee. 
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5.3.2 Surgery 
Intravenous catheters were assembled as previously described (Roberts and Koob, 1982) 
with minor modifications including a shorter length of tubing inserted into the jugular vein for 
adolescents compared with adults (2 vs. 4 cm)(Shahbazi et al., 2008). As described previously 
(Suess et al. 2020, under revision, Chapter 3 present document), incisions were made at  
midscapular and ventral neck locations, the right jugular vein was isolated, and drug delivery 
tubing was inserted into the incision in the vein. A catheter portal and backplate were implanted 
subcutaneously at the midscapular location, about 5 cm from the base of the neck. Catheter 
patency was maintained by intravenous (i.v.) administration of Timentin (ticarillin disodium and 
clavulnate potassium; 100 mg/ml), heparinized saline (100 USP units / 1ml) twice daily for three 
days post-operative, then daily for the rest of self-administration, using approximately 0.2 ml of 
each solution for adults and 0.1 ml for adolescents. Previous veterinarian consultation informed 
us that i.v. antibiotics would not influence intestinal flora. 
5.3.3 Gut microbial depletion 
After three days of surgical recovery, half the animals received an antibiotic (abx) 
cocktail in the drinking water:  Bacitracin (0.5 mg/ml), Neomycin (2 mg/ml), and Ampicillin (1 
mg/ml), as adapted from prior reports (Kanhere et al. 2018; Kiraly et al. 2016), based on 
preliminary experimentation in this laboratory. These antibiotics have broad mechanisms of 
action and target bacterial groups that are highly abundant in the gastrointestinal tract. The 
solution was prepared and changed out every 48 hours. Total solution intake per cage was 
calculated based on change in bottle mass over two days, with intake per animal estimated by 
dividing total intake by the number of animals per cage Controls received H2O only in their 
bottles. Experimental animals received abx during the 4 days of lever-press training (see below) 
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and throughout cocaine self-administration, but were switched back to H2O only at the start of 
forced abstinence. An experimental timeline for antibiotic intake is included in Figure 5.1. 
5.3.4 Gut microbial restoration 
A separate cohort of animals received antibiotics as above, but then received either 
probiotics or a placebo preparation throughout the 30 days of forced abstinence. Probio’ Stick 
(Lallemand Inc., Montreal, CN) consisted of Lactobacillus helveticus R0052 and 
Bifidobacterium longum R0175, along with malic acid and xylitol, and was mixed with 
phosphate buffered saline (PBS) to form a suspension that contained 10 x109 colony forming 
units (CFUs). Probiotic and placebo were made daily and administered to subjects at a volume of 
0.5 ml at 09:00 hr, per previous reports (Tillmann et al., 2018) with some alterations. Briefly, 
subjects were lightly restrained with a cloth towel in red-light illumination during their dark 
phase. A syringe containing the preparation was presented at the animal’s mouth with the tip just 
touching the animal. If the animal did not consume the solution after a few seconds, the tip was 
inserted into the animal’s mouth behind the teeth. Contents were expelled over approximately 10 
sec. As animals habituated over 3-10 days to the preparations and procedures, each of them 
transitioned to approaching the syringe tip in home cages consume freely. Any remaining 
probiotic or placebo preparation was recorded but negligible. An experimental timeline for 
probiotic intake is included in Figure 5.1. 
5.3.5 Feces collection, water intake, and body mass 
To collect fecal samples, rats were held by the base of the tail so that the front paws were 
on a solid surface and the back paws were gently lifted up and down off of the surface until a 
fresh fecal pellet was released. When animals were in operant conditioning chambers, fecal 
pellets were simply collected from the sterile tray under the animal. Samples were placed in 
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collection tubes on ice then moved to a -80 oC freezer for storage. Water intake was assessed 
during training and self-administration, and every three days during forced abstinence Body 
mass was assessed daily during testing, then twice weekly during abstinence. 
5.3.6 Cocaine self-administration 
Cocaine self-administration procedures were adapted from previously experiments (Suess 
et al. 2020, in revision). Briefly, animals acquired lever pressing behavior over four days via a 
negative reinforcement procedure (contingent removal of an aversive white noise stimulus) in 
daily 2-hr sessions in operant conditioning chambers (Med Associates, Inc., St. Albans, VT, 
USA), after which cocaine infusions (0.36 mg/kg/ infusion) were paired with white noise 
removal for two sessions, then lever-pressing resulted in cocaine infusions only for eight 
additional sessions conducted over ten days (with a two-day weekend recess). During cocaine 
sessions (but not the first four white noise training sessions), the catheter portal was attached to 
polyethylene tubing that led to a variable-speed syringe pump (Med Associates, Inc., St. Albans, 
VT, USA) which delivered drug solution via a stainless-steel swivel (Instech Laboratories, Inc., 
Plymouth Meeting, PA, USA). Sessions were conducted under a fixed ratio (FR)-1 schedule of 
reinforcement with a timeout after each drug infusion (20 sec). Reinforced lever-presses also 
triggered a cue-light above the active lever to come on for 2 sec, and a house light to go off for 
20 sec. Responses on a separate inactive lever were recorded but had no scheduled 
consequences. A subset of control rats went through the same procedures but always had saline 
in the syringes, rather than cocaine.    
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Figure 5.1 Experimental design for administering antibiotics and probiotics to alter 
cocaine related behaviors 
 
a. Adolescent (PND 22) and adult (PND 70-74) male Wistar rats arrive at Georgia State 
University. Baseline measurements of weight, drinking behavior, and fecal microbiota are 
collected. Animals are implanted with indwelling jugular vein catheters for drug self-
administration. b. Animals acquire lever pressing behavior through a previously validated white 
noise training paradigm (4 days). Animals subsequently self-administer cocaine with white noise 
acting as a negative reinforcer (2 days) followed by cocaine self-administration with no noise (8 
days). c. Animals then underwent two days of progressive ratio self-administration or entered 30 
days of forced abstinence. During abstinence, animals had water bottles switched to tap water 
and did not have access to the drug-taking chambers. A separate cohort of animals received 
either probiotics (Probio’ stick) or placebo via oral syringe during forced abstinence. d. Animals 
that completed forced abstinence underwent extinction and cu-induced reinstatement followed by 
sacrifice.  
 
5.3.7 Progressive ratio testing 
At the conclusion of self-administration, a subset of animals continued to self-administer 
cocaine for two days under a progressive schedule of reinforcement (PR), in which the number 
of active lever presses required for successive cocaine infusions increased based on a geometric 
progression (Roberts et al. 1993). The end of the session was achieved when animals went one 
hour without a drug infusion or a maximum of six hours. Two days of PR sessions were 
conducted on consecutive days. 
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5.3.8 Abstinence, extinction, and cue-induced reinstatement 
At the conclusion of self-administration, a separate subset of animals entered a 30-day 
forced abstinence period during which they were confined to their home cages. Subsequently, 
animals underwent extinction testing in which the animals were placed back into their chambers 
for five consecutive 1-hr sessions with no drug-paired cues or drug available. Immediately 
afterwards, animals underwent a single 1-hr reinstatement test, in which presses on the active 
lever yielded drug-paired cues including activation of the syringe pump, although no syringe was 
loaded and cocaine was still not available. 
5.3.9 Sacrifice and organ extraction 
At the end of either progressive ratio or reinstatement, animals were anesthetized with 
0.1-0.2 mls of Sodium Pentobarbital (Somnasol: Henry Schein Animal Health, Melville, NY ) 
and then rapidly decapitated. Trunk blood was collected in EDTA blood collection tubes (BD 
microtainer, Franklin Lakes, NJ) then spun at14,000 RPM for 20 minutes to separate out serum 
then stored at -20 °C for downstream analysis. Brains were flash frozen in chilled isopentane on 
dry ice then stored at -80 °C for downstream applications. Abdominal organs including cecum, 
distal colon (1 cm closest to rectum), spleen, and liver were dissected and transferred to dry ice 
then to -80 °C for downstream analysis. Mass and photographs of abdominal organs were also 
collected. 
5.3.10 DNA extraction and qPCR for bacterial DNA 
Identification of changes in total bacterial load was conducted as previously described 
(Kanhere et al. 2018). In brief, fecal samples were homogenized and DNA extracted according to 
the Earth Microbiome Project (www.earthmicrobiome.org/emp-standard-protocols). DNA was 
isolated using the PowerSoil DNA Isolation Kit (Qiagen, Germantown, MD). The V4 region of 
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the 16S rRNA genes was amplified with quantitative polymerase chain reaction (qPCR). Specific 
procedures, forward and reverse primers were adapted from previous work (Kanhere et al. 2018) 
with minor adjustments. Fold change in total bacterial load is calculated by normalizing to DNA 
content as described previously (Caporaso et al. 2012). Samples were taken before behavioral 
testing (Pre), at the conclusion of cocaine self-administration and/or antibiotic intake (Peak), and 
after 30 days of abstinence (Post). 
5.3.11 Microbiota composition analysis via 16S rRNA sequencing. 
Fecal samples from the timeline listed above were processed to identify microbiota 
composition, as previously described (Chassaing et al., 2015; Suess et al. 2020b). Briefly, DNA 
from fecal samples were extracted using QIAamp 96 Powerfecal QIAcube HT Kit (Quiagen, San 
Diego, CA) with mechanical disruption (bead-beating). 16S rRNA genes, region V4, from each 
sample were PCR amplified using a composite reverse primer and a forward primer containing a 
unique 12-base barcode used to tag PCR products from respective samples. PCR products were 
purified with magnetic beads (Beckman Coulter, Brea, CA), visualized by gel electrophoresis 
and quantified using Epoch Microplate Spectrophotometer (Biotek, Winooski, VT). A master 
DNA pool was generated and sequenced using a Illumina MiSeq (2*250 bp, paired end) at 
Cornell University. 
5.3.12 Fecal Lipocalin-2 
Inflammation in fecal samples was assessed as previously described (Chassaing et al. 
2012). Briefly, frozen fecal samples were reconstituted with PBS/0.1% Tween 20 then vortexed 
to get homogenous solution. After centrifugation for 10 mins at 12,000 rpm, clear supernatants 
were collected for analysis. Supernatants were used as input for the Duoset rat Lcn-2 ELISA kit 
(R&D Systems, Minneapolis, MN) and followed according to manufacturer’s instructions. 
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Quantification of lipocalin was assessed using a spectrophotometer and plotting absorbances 
against a standard curve. 
5.3.13 16S rRNA sequences analysis 
Sequencing outputs were analyzed at Georgia State University, as previously described 
(Chassaing et al., 2015; Suess et al. 2020b). Briefly, sequence outputs were demultiplexed, 
quality filtered using the Quantitative Insights Into Microbial Ecology (QIIME) software 
package (Caporaso et al., 2012), and forward and reverse Illumina reads were joined using the 
fastq-join method (http://code.google.com/p/ea-utils) (Aronesty, 2013). QIIME default 
parameters were used for quality filtering and sequences were assigned to OTUs using the 
UCLUST algorithm (Edgar, 2010) with a 97% threshold of pairwise identity and classified 
taxonomically using the Greengenes reference database (McDonald et al., 2012). Principal 
coordinate analysis of the unweighted UniFrac distances was used to assess the variation 
between samples (beta diversity) (Lozupone et al., 2011). Beta diversity was further visualized 
via jackknife-supported PCA plots. Alpha diversity and rarefaction curves were calculated and 
displayed using Observed OTUs as through the use of QIIME. 
5.3.14 Statistics  
Self-administration behavior was analyzed via a mixed-model analysis of variance 
(ANOVA) in a 2 x 2 x 2 design with age (adolescents vs adults), drug (cocaine vs saline), and 
antibiotic treatment (abx vs H2O) as between-subject variables and active lever-presses or 
number of infusions as the primary dependent measures. Sham controls and saline controls were 
collapsed into a single control group. Comparison of total cocaine intake (mg/kg) was conducted 
using independent samples t-tests (two-tailed). PR responding was compared using number of 
infusions as the dependent measure. Extinction and reinstatement analyses were split into 
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separate tests. Results from animals receiving probiotics or placebo during abstinence were 
analyzed similarly but separately, using univariate ANOVA, with presses on the previously 
active lever presses as the dependent measure and age, probiotic treatment, and session as 
independent variables. Fecal lipocalin-2 was analyzed using a mixed-model ANOVA, with age 
(adolescents vs adults), drug (cocaine vs saline), and antibiotic treatment (abx vs H2O) as 
between-subjects variables and time point (Pre, Peak, and Post) as the within-subjects factor. 
Alpha was set at .05 in all cases.  Any post-hoc comparisons were conducted using Tukey’s 
Range Test.   
Fecal qPCR abundance results are presented as change in cycle threshold (ΔCT), 
normalized to an animal’s pretreatment phase (Pre), on a logarithmic scale. Abundance 
differences were assessed using a similar ANOVA test as behavior but inserting sample 
timepoint as a repeated measure. For between-subject microbiota diversity, differences in distinct 
clustering in PCA plots was assessed via PERMANOVA method using vegan R-package 
through QIIME. 
All data were analyzed using SPSS v.23 (SPSS, Chicago, IL). Behavioral data, lipocalin-
2, and qPCR graphs were generated in PRISM 7/ GraphPad software. Between and within 
groups diversity graphs were generated via QIMME. LEfSe and cladograms were generated 
using the online Galaxy tool (http://huttenhower.sph.harvard.edu/galaxy/). 
5.4 Results 
5.4.1 Gut microbial depletion alters host physiology 
Neither cocaine or antibiotics in the drinking water altered body mass (Supplemental 
Figure 5.1) or fluid intake (Supplemental Figure 5.2) during the course of the experiment. 
Neither cocaine or antibiotics influenced spleen, liver, or intestinal mass at sacrifice (data not 
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show). Animals in the antibiotic treatment group had larger ceca compared to water controls, 
regardless of age. In adults, the effect of cocaine in antibiotic treated rats further increased cecum 
mass (F=28.96, p<0.001), an effect not observed in adolescent counterparts (Figure 5.2 a). 
Furthermore, differences in the cecum were visually apparent between antibiotic- and water-
treated groups (Figure 5.2 b). Specifically, antibiotic treated animals had longer and wider ceca 
(and a more leathery texture) compared to water controls. Ceca also appeared darker and 
appeared to contain more fecal material. Inflammation was not altered by cocaine or antibiotics 
experience, as measured using the fecal lipocalin-2 biomarker (Supplemental Figure 5.3). 
 
 
Figure 5.2 The influence of antibiotics and cocaine on cecum mass and size 
a. Total cecum massed assessed at sacrifice. Antibiotic intake was associated with increased 
cecum weight in both adolescents and adults. Cocaine further increased cecum weight in adults 
but not adolescents. b. Photographs illustrating the effect of antibiotics on cecum size. All error 
bars are ±S.E.M. 
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5.4.2 Gut microbial depletion does not alter self-administration behavior 
During self-administration, neither age nor antibiotic treatment altered rates of active 
lever presses (Figure 5.3 a) or cocaine infusions (Figure 5.3 b). Cocaine animals had more active 
lever presses and total cocaine infusions during periods when drugs were available compared to 
saline controls. In cocaine treated animals, neither age nor antibiotic treatment altered total 
cocaine intake (Figure 5.3. c). In animals that subsequently underwent PR self-administration, no 
age or antibiotic effects on cocaine infusions were observed on either test day (Supplemental 
Figure 5.4 a) and day 2 (Supplemental Figure 5.4 b). Furthermore, neither age nor antibiotic 
treatment altered lever pressing during PR (Supplemental Figure 5.4). 
 
Figure 5.3 Antibiotic influence on cocaine self-administration 
a. Animals that were administered cocaine had higher levels of active lever presses compared to 
no cocaine controls. Neither age nor antibiotic treatment altered total active lever presses. b. 
Animals taking cocaine earned more infusions than no-cocaine controls, but neither age nor 
antibiotic treatment altered total infusions. c. Neither age nor antibiotic treatment altered total 
cocaine intake. Vertical lines show onset of cocaine availability. All error bars are ± S.E.M. 
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5.4.3 Gut microbial depletion exacerbates cocaine-seeking behavior in adults but not 
adolescents 
Cocaine experienced animals had higher rates of active lever-pressing during extinction 
and cue-induced reinstatement, compared with saline controls (F=4.94, p=0.004) (Figure 5.4). 
Adult cocaine animals had more presses during the reinstatement if they had received antibiotics 
during self-administration compared to their age-matched water treated counterparts (F=21.92, 
p=0.02) (Figure 5.4 b), an effect not observed in adolescent counterparts. Adult cocaine groups 
that had received antibiotics also trended toward higher extinction responding, but this was not 
statically significant.  
 
Figure 5.4 How inducing gut dysbiosis via antibiotics alters extinction responding and 
cue-induced reinstatement 
Animals that self-administered cocaine had higher levels of total extinction presses compared to 
no cocaine counterparts (##) (left panel). Neither age nor antibiotics influenced extinction 
behavior. Animals that self-administered cocaine had higher levels of reinstatement presses 
compared to no cocaine counterparts (##) (right panel). Adults that experienced dysbiosis via 
antibiotics had higher levels of reinstatement compared to no antibiotic counterparts (*) (right 
panel). This effect was not observed in adolescent counterparts. All error bars are ±S.E.M. 
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5.4.4 Antibiotics alter the microbiota’s abundance in an age specific manner 
The microbiota was sampled at three different time points in the experiment (Figure 
5.5a). Animals of both age groups with antibiotic experience showed a nearly 100 fold decrease 
in bacterial abundance compared to baseline levels, an effect not seen in water controls (Figure 
5.5 b,c). Yet adolescent subjects with antibiotic experience recovered to baseline abundance 
levels after the 30 days of abstinence whereas adults remained dysbiotic after 30 days (Figure 5.5 
b,c). Cocaine exposure did not influence these effects of antibiotics on bacterial abundance. 
 
Figure 5.5 The influence of antibiotics and cocaine on gut microbiota abundance 
a. Diagram of the experimental timeline with stars representing the key timepoints of fecal 
collection. Samples taken before cocaine/ abx administration (pre), samples taken right after 14 
days of cocaine intake and antibiotic intake (peak), and samples taken after 30 days of abstinence 
from cocaine and antibiotics (post). b. In animals that have cocaine, antibiotics illicit a sharp 
decrease in gut microbial abundance. Adolescent animals recover to near baseline levels after the 
30 day washout, but adult animals still have a dysbiotic gut after 30 days. c. Saline animals show 
a similar effect, demonstrating that antibiotics are the primary facilitator of this effect. Both 
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cocaine d. and saline e. animals that were not exposed to antibiotics do not show a significant 
decrease in gut microbial abundance (although a small decrease was observed in adolescent 
animals at the peak timepoint). All error bars are ±S.E.M. 
 
5.4.5 Microbiota diversity and richness is altered by antibiotics and cocaine in a time 
dependent manner 
In adult subjects we observed that the microbiota profile was altered by cocaine when 
comparing baseline (pre) samples with end of experiment (post) samples (p=0.003) (Figure 5.6; 
left panel). Irreversible microbiota changes are also observed in antibiotic treated vs water 
treated animals at pre and post (p=0.002) (Figure 5.6; right panel). While alpha diversity is 
unchanged in adults when looking at our perturbations (Supplemental Figure 5.5 a and c), we 
observe that taxa which contribute to microbiota profiles are different between adult control and 
adult cocaine animals as well as adult H2O and adult abx animals (Supplemental Figure 5.5 b and 
d).  
 
Figure 5.6 Gut microbiota changes in adults 
Among adult rats, cocaine self-administration shifted microbiota diversity (left), as did abx 
intake (right).  
 
When investigating the microbiota composition of adolescent subjects, we also see a shift 
due to cocaine intake between baseline and post (p=0.005) (Figure 5.7;left). When looking at 
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antibiotic’s contribution to the adolescent microbiota we see that antibiotic and non-antibiotic 
subjects have similar diversity profiles between pre and post (p=0.567) (Figure 5.7; right). While 
alpha diversity was unchanged in adolescents (Supplemental Figure 5.6 a and c), we do observe 
that taxa which contribute to microbiota profiles are different between adolescent control and 
adolescent cocaine animals (Supplemental Figure 5.7 b). Even though adolescent H2O and 
adolescent abx animals have no differences in microbiota diversity, they do show robust 
differences in individual taxa when assessed via LEfSe (Supplemental Figure 5.6 d). 
 
 
Figure 5.7 Gut microbiota changes in adolescents 
Among adolescent-onset groups, cocaine self-administration shifted microbiota diversity (left), 
but abx intake did not (right). 
 
 
5.4.6 Probiotic administration affected host physiology 
Neither probiotic nor placebo administration during abstinence altered normal body mass 
and fluid intake compared to prior cohorts of animals that did take cocaine during abx treatment 
but were not syringe fed during abstinence (data not shown). Furthermore, neither probiotics nor 
placebo altered the mass of spleen, liver, or distal colon (data not shown). Although difficult to 
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analyze due to small group size and missing data for a no-cocaine, placebo-control group, it 
appeared as though adolescent-onset groups taking cocaine had smaller cecum mass than 
cocaine-naïve controls, an effect that was not altered by probx treatment. Among adults, cocaine 
self-administration did not appear to alter cecum mass, but probx treatment did decrease cecum 
mass, with significant effects in the cocaine-experienced animals. Non-significant outcomes in 
the saline-treated controls is due to low n (=1) for the saline-probx treatment group. (figure 5.8). 
 
Figure 5.8 Probiotics attenuate cecum size 
Adolescent animals that had probiotics and cocaine had a smaller cecum mass compared to 
saline placebo counterparts. In adults that took cocaine, probiotics resulted in a smaller cecum 
mass compared to placebo counterparts. All error bars are ±S.E.M. 
 
5.4.7 Probiotics alter cocaine seeking in an age dependent manner 
In tests of extinction and reinstatement of cocaine-seeking after 30 days of abstinence and 
probiotic (or placebo) treatment, animals that took cocaine had higher extinction (t(24)=3.14, 
p=0.004)  and reinstatement responding compared to no cocaine controls, as expected 
(t(24)=2.20, p=0.038); Figure 5.9 a, b). Among adults, probiotic treatment decreased rates of 
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reinstatement responding among cocaine-experienced rats (t(9)=3.76, p=0.005) but this effect 
was not significant in adolescent-onset groups (figure 5.9 c). To account for failure among some 
rats to extinguish their lever-pressing during the five extinction tests, we calculated a Change 
Score by subtracting the number of active lever-presses during last extinction session (ext5) from 
the number of presses during the single reinstatement test session. Again, cocaine-experienced 
rats showed higher change scores than no-cocaine controls (t(24)=2.24, p=0.0349), and the 
probiotic treatment decreased change scores in adults (t(9)=7.08, p<0.001), but not adolescent-
onset groups. 
 
Figure 5.9 Probiotics modulate cocaine-seeking 
a.Neither age nor probiotic treatment altered extinction responding in the first 1-hr session, but 
cocaine-experienced animals pressed more on the previously active lever than controls (##). b.  
Neither age nor probiotic treatment altered extinction responding over all extinction sessions 
combined, but cocaine-experienced animals pressed more on the previously active lever than 
controls (##). c. Cocaine-experienced animals pressed more on the previously active lever than 
controls (##) during the 1-hr reinstatement test, and probiotics attenuated reinstatement 
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compared to placebo controls in adults but not adolescents (*). d. Similarly, cocaine-experienced 
animals showed a greater change between the last extinction session and 1-hr reinstatement 
session, compared with controls (##), and probiotics reduced the change score compared to age-
matched placebo controls in adults but not adolescents (*). All error bars are ±S.E.M. 
 
5.5 Discussion 
The present experiment tested the hypothesis that antibiotic-induced microbial depletion 
in the gut would exacerbate cocaine reward and reinforcement in adult male rats, with similar or 
reduced effects among adolescent male rats. This hypothesis was partially supported in that rates 
of cocaine self-administration were not affected by antibiotic treatment in either age group, but 
enduring effects of cocaine were indeed exacerbated as measured by rates of cue-induced 
reinstatement of cocaine-seeking after 30 days of forced abstinence, an effect observed in adults 
but not adolescent-onset treatment groups. Moreover, preliminary results included in this 
experiment lend support for the additional hypothesis that probiotic treatment during forced 
abstinence could rescue and/or further reduce normal levels of cue-induced reinstatement, such 
that adults receiving probiotics reinstated to lower levels than their placebo-treated, age-matched 
counterparts. As with antibiotics, the probiotic effects were not robust among adolescent-onset 
groups, although this portion of the experiment is hampered by low numbers of animals in each 
treatment group.  
The antibiotic cocktail provided to rats in this study was effective at depleting the gut of 
the normal robust bacterial communities, as demonstrated by qPCR estimating overall bacterial 
abundance and confirming prior reports with a similar cocktail provided to adult male mice 
(Kiraly et al. 2016). All groups administered antibiotics for 14 days had their microbiota 
significantly depleted by over 100 fold. After 30 days of washout, adolescents had their 
microbiota return to baseline levels, whereas adults remained dysbiotic. On the other hand, 
cocaine self-administration alone did not reduce overall gut microbial abundance in either age 
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group. With regard to age differences in the timeline of recovery from the antibiotic insult, the 
microbiota may reach a stable state and become somewhat difficult to reshape in adulthood 
(Lozupone et al. 2013), such that only extremely stressful stimuli can cause a shift (stress, 
antibiotics, diet, etc). While perhaps beneficial under normal conditions associated with 
maintenance of homeostasis (Arumugam et al. 2011), this quality may prevent adults from 
recovering their microbiota over a 30-day “washout” after a 14-day antibiotic treatment. Faster 
recovery to baseline among younger animals could relate to greater fluctuation during 
development (Mohammadkhah et al. 2018; Tanaka et al. 2017; Borre et al. 2017) and reports that 
adolescent microbiota are still in unstable states, distinct from adults (Neufeld et al. 2011, Agans 
et al. 2011, Derrien et al. 2019).  
Adolescence is a stage of rapid developmental with many physiological changes 
occurring including alterations in brain circuitry, hormones, and behavior. Researchers are now 
starting to piece together that these developmental changes occur on a similar timepoint as gut 
microbe maturation (Borre et al. 2014, Jasarevic et al. 2016). While many reports classify 
adolescence as a period of vulnerability, there are many instances when these rapid 
developmental changes can confer resiliency. Changes in physiology are thought to vital for 
adolescent vitality as they allow for adaptation to novel environments away from their parents. 
The combination of risk taking behavior and qualities that conifer resiliency are adaptive in 
allowing animals to seek out environments, individuals, and habitats that will allow them to be 
fit adults (Schramm-Sapyta et al. 2006). Drugs of abuse and antibiotics both have aversive 
qualities, throwing the body out of homeostasis. The above evidence would suggest that 
alterations in animal behavior through these aversive behaviors would be less robust in 
adolescents compared to adults due to resiliency. 
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The present antibiotic treatment exerted additional physiological impact in the gut. For 
example, antibiotics increased cecum mass regardless of age, an effect that was exacerbated by 
cocaine self-administration in adults, but not adolescents. Both antibiotics and germ-free 
conditions have previously been shown to increase cecum mass and size in mice (Kiraly et al. 
2016; Grover et al. 2015). Although antibiotics and cocaine both induce inflammation in the 
gastrointestinal tract (Sun et al. 2019; Knoop et al. 2016; Chievero et al. 2019; Volpe et al. 2014; 
Linder et al. 2000), elevated cecum mass in the present experiment was not associated with 
elevated levels of the inflammatory marker, Lipocalin-2. Indeed, Lcn-2 levels were at or below 
the threshold of detection when using the same kit with mice (Chassaing et al. 2012,). It is 
possible that Lcn-2 is too limited as a marker of inflammation, as it is mainly expressed in 
neutrophils (Chassaing et al. 2012; Kjeldsen et al. 2000), but it is also possible that the increase 
in cecum mass could result instead from reduced gastric motility in the absence of bacteria that 
aid in digestion (Raja et al. 2018). Regardless, it seems that probiotic treatment may restore 
normal cecum mass, at least in adults. It could be the case that probiotics also keep cecum mass 
low in adolescent-onset groups, given a trend toward lower cecum mass in the probiotic-treated 
adolescent-onset group, compared to the no-cocaine, placebo controls. Yet the placebo-treated 
cocaine self-administration group did not show elevated cecum size either and the present dataset 
is too small to draw strong conclusions.  
Gut microbial depletion was not associated with changes in acute cocaine-related reward 
and reinforcement, as measured by rates of acquisition and maintenance of cocaine self-
administration on a schedule of reinforcement incurring low behavioral cost, i.e. FR1, 2-hr daily 
sessions, or on a schedule of reinforcement that measures acute reinforcing efficacy, i.e. PR, 
maximum 6-hr sessions. The overall trends in acquisition of lever-pressing using white noise 
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negative reinforcement, the transition to cocaine self-administration, and lack of age differences 
in overall cocaine intake replicates previous reports from our group (Suess et al. 2020a, Li et al. 
2009). The lack of antibiotic impact on cocaine reward and reinforcement could be related to the 
present timeline of experimentation, i.e. gut bacterial populations may not yet have been depleted 
sufficiently by the time the rats were associating lever-pressing with cocaine reward. 
Alternatively, parameters of cocaine self-administration that incur higher behavioral cost such as 
higher FR requirements, second-order schedules, repeated PR testing, or models of compulsive 
drug-seeking in the face of aversive stimuli such as shock or aversive white noise, may be 
required to expose the short-term impact of gut-brain signaling on self-administration behavior. 
It is also possible that alterations in the microbiota do not play a role in the operant conditioning 
associated with cocaine self-administration, even though it did alter the classical conditioning 
required to demonstrate cocaine conditioned place preference in mice (Kiraly et al 2016).   
The major finding in this report is that antibiotic treatment during cocaine self-
administration was associated with higher rates of cue-induced reinstatement after 30 days of 
forced abstinence, but probiotic treatment during abstinence rescued lower levels of 
reinstatement, among adult rats. In the first phase of experimentation, antibiotic treatment 
increased reinstatement by approximately 33%, whereas in the second phase of experimentation, 
probiotic treatment decreased reinstatement by about 50%. Notably the levels of reinstatement 
among antibiotic treated rats was different across experimental phases, i.e. average 120 presses 
in the first phase vs. only 80 presses in the second phase, but nonetheless, the probiotics in the 
second phase still reduced reinstatement responding further down to average 40 presses. The 
absence of effect of gut manipulations on extinction responding is not unexpected, as the effect 
of age on enduring impact of cocaine, heroin, or morphine has varied across experiments from 
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our group to include both, one, or the other (Li et al. 2009; Doherty et al. 2009; Doherty et al. 
2013). Furthermore, a trend toward probiotic effect on extinction responding among adults could 
become more robust when complete treatment groups are examined. The absence of effect of gut 
manipulations on extinction and reinstatement among adolescents could be related to the shorter 
timeline of gut dysbiosis in the younger rats; as noted above, overall bacterial abundance appears 
to have returned to baseline by the time of extinction and reinstatement testing. These findings 
support previous evidence that adolescent animals are resilient and protected from several 
aversive stimuli, particularly drugs of abuse (Ator and Griffiths 2003; Frantz et al. 2006; 
Schramm-Sapyta et al. 2009; Shram et al. 2008; Doherty and Frantz 2013; Hodgson et al. 2009; 
O’Dell et al. 2007; Schramm-Sapyta et al. 2006; Silveri Marisa et al. 2006). It remains possible 
that the probiotic could further decrease extinction and/or reinstatement responding among 
adolescent-onset groups, as a trend toward reduction is observed at present, despite the small size 
of treatment groups to date.  
Beyond microbial abundance, we profiled the bacterial communities from fecal samples 
in order to test for differences in diversity between or within treatment groups that might relate to 
age or cocaine experience. Perhaps not surprisingly, the microbiome was significantly different 
across age groups at the pre-antibiotic/pre-cocaine baseline timepoint. This expands on previous 
reports that adolescents and adults have distinct gut profiles (Agans et al. 2011) to reveal several 
microbial groups that have higher relative abundance among adolescents than adults, and vice 
versa. We also observed that cocaine was associated with a shift in microbial composition in 
both age groups that persists through 30 days of washout, despite the lack of effect of cocaine 
alone on bacterial abundance and despite a return to baseline abundance levels among 
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adolescents by that time point. In the context of antibiotic effects, measures of diversity shifted 
with antibiotic exposure and recovery among adults, but did not change among adolescents..   
The LEfSe analysis reveals bacterial groups of potential interest for future investigation. 
For example, the genus Prevotella was robustly expressed in adult cocaine vs. control subjects 
and appears related to peripheral inflammation (Larsen et al. 2017). Interestingly, the genus 
Coproccus was robustly expressed in adolescent cocaine groups and adult antibiotic groups and 
is linked to depression (Valles-Colomer et al. 2019). On the other hand, taxa observed with 
higher relative abundance among adolescent cocaine-experienced rats vs. their age-matched 
controls have been associated with mental health (Valles-Colomer et al. 2019) and SCFA 
production (Machiels. et al 2014). This comes as a surprise given that SCFA supplementation 
has been shown to attenuate cocaine related behaviors (Kiraly et al. 2016). It is possible that 
SCFAs do not alter reward sensitivity in adults as they do in adolescents. Further studies should 
test whether SCFAs are altered in an age dependent manner in response to antibiotics and/or 
cocaine. 
The mechanisms through which cocaine might change gut microbial communities remain 
to be explored, but several possibilities exist. For example, cocaine certainly activates the 
sympathetic nervous system and hypothalamo-pituitary axis, which exerts significant impact on 
gut function. Cocaine also changes compromises pulmonary function (Maceira et al. 2014), 
triggers inflammatory responses (Fox et al. 2012), and damages the mucosal membrane around 
the gut (Chivero et al., 2019), inducing colitis or other gut related disorders (Linder et al. 2009), 
or actually perforating the duodenum or other gastric tissue (Feliciano et al. 1999; Uzzaman. et 
al. 2010). Indirectly, cocaine alters dietary regimens among users (Ersche et al. 2013) and 
170 
decreases in body weight (Cochrane et al. 1998). These cocaine effects alter the gut milieu, with 
potential to promote or inhibit growth of specific bacterial populations.  
Mechanisms through which the gut milieu influences behavioral reward and 
reinforcement also warrant investigation. Microbial depletion that enhanced cocaine reward was 
also associated with abnormal levels of reward-related transcripts in the nucleus accumbens 
(Kiraly et al. 2016), providing an example of brain changes after gut manipulations. Gut 
microbes may influence brain function via vagal signaling, as microbial metabolites appear to 
activate the vagus nerve, potentially reaching limbic system and striatal targets through a synapse 
in the nucleus tractus solitarius (NTS) (Han et al. 2018). In fact, vagotomy eliminates beneficial 
probiotic effects through GABA receptors (Bravo et al. 2011). Moreover, gut dysbiosis may 
result in changes in peripheral cytokines, transmitter precursors, SCFA, and other neuroactive 
molecules that normally reach the brain via circulation (Cryan et al. 2012).  
While this report provides details on the relationship between the gut microbiota and 
substance use disorder, there are some limitations that should be addressed in future studies. The 
National Institutes of Health (NIH) and other government-funded agencies have initiated 
mandates to use both sexes for research designs, analysis, and reporting unless due justification 
is claimed. Sex differences in drug related behaviors have been extensively reviewed with men 
using illicit drugs more frequently (Abuse et al. 2013) but women escalating drug use more 
quickly than men (Lynch et al. 2002; Brady et al. 1999). Sex differences in the gut microbiota 
composition have also been reported (Org et al. 2016; Kim et al. 2020). We fully support 
subsequent experiments that investigate our findings in females. This study also provides 
promising results using probiotics to attenuate drug-seeking behavior. Yet it only utilizes a small 
group of animals; follow-up experiments will increase the power of analysis. Furthermore, this 
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report does not investigate brain adaptations in response to microbial alterations. Analysis of 
reward related brain regions and examination of dysregulation of reward related transcripts/ 
proteins, or synapse activation or function are a logical next-step identifying gut to brain 
interactions. Expanding to examine whether similar gut-behavior interactions exist with other 
commonly abused substances such as alcohol, heroin, or amphetamines is also important.   
In conclusion, the present experiment suggests a critical role for gut health in attenuating 
cocaine reward and reinforcement, at least among adult subjects. Whereas antibiotics 
significantly altered gut bacterial communities and elevated reinstatement of cocaine-seeking 
after abstinence among adult male rats, probiotic treatment during abstinence brought 
reinstatement levels back down below control levels. Although these effects of gut microbial 
depletion were not robust in adolescent male rats, the probiotic treatment might still be 
associated with lower levels of reinstatement of cocaine-seeking in younger subjects, based on a 
trend in the current results with relatively few animals per treatment group. These datasets 
suggest that probiotics may serve as an affordable, accessible, and effective adjunct treatment for 
cocaine abuse.  
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5.6 Supplemental Figures 
 
Supplemental Figure 5.1:  The influence of antibiotic and cocaine on body mass throughout the 
experiment.  
Progression of body weight factoring age (Peri vs adult), antibiotics (abx vs H2O), and drug (a. 
cocaine vs. b. saline). Dashed line represents onset of antibiotics and solid line represents 
cessation of antibiotics. All error bars are ±S.E.M. 
 
 
 
Supplemental Figure 5.2:  Home-cage fluid intake throughout the experiment 
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No differences by age, abx treatment, or cocaine experience were observed. All error bars are 
±S.E.M. 
 
Supplemental Figure 5.3:  Peripheral gut inflammation measured by fecal lipocalin-2. 
Using the marker fecal lipocalin-2 (Lcn-2) we observe that neither cocaine nor antibiotics alter 
the inflammatory response. All error bars are ±S.E.M. 
 
 
Supplemental Figure 5.4:  How inducing gut dysbiosis via antibiotics affects the motivation to 
seek out cocaine through a progressive ratio schedule.  
 
Number of infusions were not significantly different between a. day 1 and b. day 2 of 
progressive ratio self-administration. Neither age, nor antibiotics altered active lever presses 
during progressive ratio testing. All error bars are ±S.E.M. 
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Supplemental Figure 5.5 Characterization of the adult microbiota after cocaine and antibiotic 
intake 
a. Alpha diversity plots show no difference between cocaine and non-cocaine adults at sacrifice. 
b. However, several bacterial groups are in higher relative abundance among cocaine or control 
groups (green or red, respectively). c. Alpha diversity plots show no difference between H2O and 
antibiotic adults at sacrifice, d. However, several bacterial groups are in higher relative 
abundance among antibiotic or control groups (green or red, respectively).  
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Supplemental Figure 5.6 Characterization of the adolescent microbiota after cocaine and 
antibiotic intake 
a. Alpha diversity plots show no difference between cocaine and non-cocaine adolescents at 
sacrifice. b. However, several bacterial groups are in higher relative abundance among cocaine 
or control groups (green or red, respectively). c. Alpha diversity plots show no difference 
between H2O and antibiotic adolescents at sacrifice. d. However, several bacterial groups are in 
higher relative abundance among antibiotic or control groups (green or red, respectively).  
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Supplemental Figure 5.7:  Adolescent and adult microbiota profiles are distinct 
a. Using PCA beta diversity analysis we find that adolescents (sampled at PND 25) and adults 
(sampled at PND 73-77) cluster distinctly. b. LEfSe shows that several bacterial groups are in 
higher relative abundance among adolescents or adults (green or red, respectively).  
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Supplemental Figure 5.8 Active lever-presses during cocaine self-administration before 
probiotic treatment. 
Animals taking cocaine had higher levels of active lever presses compared to no-cocaine 
controls. Age groups did not differ in active lever presses and no differences at baseline existed 
between future probiotic vs. placebo treatment groups. All error bars are ±S.E.M.  
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6 CONCLUSIONS  
6.1 Summary of findings 
Adolescence is a period of development in which risk-taking, novelty-seeking, and 
exploration are heightened (Spear et al. 2000). While these qualities may predispose 
adolescents towards initial drug use and abuse, adolescents also possess resilience factors 
that appear protect them from aversive stimuli (Schramm-Sapyta et al. 2006; Shram et al 
2008; Doherty et al. 2013; O’Dell et al. 2007). A major goal of this research is to identify 
what makes adolescents and adults different in their drug seeking behavior. While evidence 
has shown that under maturation of prefrontal cortex, limbic system, and other reward related 
brain regions may be responsible for heighted drug use and poor judgement (Spear et al. 
2000), the role of an equally underdeveloped gut microbiota is vastly underexplored.  
We have several lines of evidence show that adolescent rodents are less sensitive to 
aversive stimuli, both in terms of how these stimuli modulate behavior and the gut 
microbiota. Through the use of a white noise stimuli as a negative reinforcer we are able to 
facilitate lever pressing in operant conditioning chambers in both adolescent and adult male 
rats. This method can be extended to multiple different types of research designs. White 
noise generators are easy to install, are inexpensive to purchase and maintain, can be fine-
tuned by the experimenter based on current needs, and do not cause harm or pain to the 
subject. White noise used as a positive punisher also attenuates cocaine seeking behavior in 
adults but not adolescents, again reinforcing the idea that adolescents are less vulnerable or 
resistant to aversive stimuli. 
The relationship between the gut microbiota and substance use disorder is 
underexplored. We attempted to determine whether the high variability we observe in 
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cocaine taking behavior was related to specific gut microbiota profiles. Results show that the 
microbiota in drug naïve individuals is similar but begins to differentiate and become unique 
throughout cocaine exposure. In addition, the use of particular microbiota taxa at baseline 
can be used as a diagnostic tool to predict the severity of future drug use. Both of these 
findings can be used to assist clinicians in diagnosing whether casual drug use will develop 
into severe addiction or if children have microbiota profiles that may be early indicators of 
future maladaptive phenotypes. 
Illicit drug use possess a huge economic and healthcare burden on society (French et 
al. 2008; Whiteford et al. 2013; Patel et al. 2016). Tools to predict future drug use as well as 
medications to attenuate current use are ineffective. Persons who successfully moderate or 
abstain from drug use tend to fall back into addictive habits or relapse. To that end there are 
currently no successful therapies that significantly prolong abstinence and prevent relapse in 
cocaine abuse. Our research sought to examine whether manipulation of the gut microbiota 
alters the rewarding aspects of cocaine. Adult rats that experienced antibiotic induced gut 
microbial depletion had increases in reward seeking behavior measured by the cue-induced 
reinstatement model. These findings were not seen in adolescent counterparts, even though 
antibiotics resulted in a similar reduction in abundance and diversity in the microbiota. A key 
finding was that adolescent animals had their microbiota return to baseline levels after thirty 
days of washout, while adults remained dysbiotic. This resilience shown by adolescent 
subjects seems to protect them from the enduring effects of antibiotics and cocaine. This 
resilience to aversive stimuli may protect adolescent subjects from the vicious cycle of drug 
abuse. Outside stimuli such as diet, stress, and antibiotics alter the microbiota composition. 
Altered microbiota composition may change gut produced metabolites and neuroactive 
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molecules, which through either direct signaling pathways or indirect pathways through 
circulation may alter brain function. Alterations in brain function, particularly in reward 
related brain regions could result in further maladaptive behavior towards harmful stimuli. 
While cocaine intake does not alter microbiota abundance it does create a shift in diversity 
and species richness that persists even through a 30 day period of cocaine abstinence. 
Cocaine being an aversive stimuli, may perpetuate the vicious cycle of cocaine addiction 
more severely in adults vs adolescents due to the inability of the microbiota to bounce back 
to health levels. 
One way that increases in drug seeking-behavior could be attenuated is returning the 
microbiota abundance and diversity back to pre-intake levels. We sought to do this using a 
probiotic formulation that has shown to alleviate other neuropsychiatric symptoms, such as 
depression and stress. Preliminary findings show that in adult animals that have experimenter 
induced gut microbial depletion, probiotic administration reduces cue-induced reinstatement. 
This finding was not observed in adolescent counterparts. It is possible that probiotics, while 
beneficial, do possess aversive qualities that the body tends to reject. This would make their 
efficacy in adolescent subjects less than adult counterparts.  
6.2 Future directions & Limitations 
While this dissertation synthesizes many new findings there are some limitations 
that must be reported. The work in this paper is conducted with male subjects only. Due 
to physiological and neural differences between males and females, as well as females 
experiencing different severity of disease states compared to males, makes the use of both 
sexes a mandate in scientific research. This is especially true in our line of work given 
that drug seeking, intoxication, withdrawal severity, and likelihood to relapse all skew 
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towards one sex. In fact, it has been reported that females initiate drug use more quickly 
than men (Lynch et al. 2002; Brady et al. 1999). Furthermore there is preliminary 
evidence that the microbiota composition is driven by sex (Org et al. 2016; Kim et al. 
2020) and that stimuli that may influence the microbiota (diet, environment, stress, etc.) 
are sex dependent. We acknowledge that the use of male subjects does have its benefits in 
reducing the number of experimental animals, as previous literature that guided our 
research was done with male animals. We also acknowledge that previous work with only 
male subjects does not paint a complete story of gut-brain-cocaine interactions and that 
females are needed to complete findings. Along with our age dependent results, we 
encourage all follow up experiments to not only have males and females, but also 
adolescent and adult counterparts. While little is known on how adolescence contributes 
to gut related changes in cocaine behavior, less is known when adding in the variable of 
sex. The use of both age groups and both sexes will advance our understanding of how 
the microbiota contributes to substance use disorder. 
These experiments contribute to previous literature that the gut microbiota is 
associated with substance use disorder (Kiraly et al. 2016; Ning et al. 2017; Meckel et al. 
2019). While it has also been shown that the gut microbiota is associated with several 
other neuropsychiatric disorders such as schizophrenia (Nguyen et al. 2019), depression 
(Peirce et al. 2019), and bipolar disorder (Flowers et al. 2020), the mechanisms 
underlying these relationships are remain unknown. Until the mechanism of this 
connection is understood, the scope of our findings and these relationships between 
neuropsychiatric disorders and the microbiota will be limited. Besides the evidence that 
the vagus nerve and circulatory factors play a part in gut brain communication (Cryan et 
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al. 2012; Cryan et al. 2019), recent findings are attempting to map out gut-brain neuronal 
circuitry and vice versa. Optogenetic activation of vagal sensory ganglion results in 
sustained self-stimulation behavior as well as dopamine release from areas of dorsal 
striatum. Neuronal labeling follow up experiments revealed glutamatergic neurons of the 
dorsolateral parabrachial region as a region that mediates gut related signals to the 
striatum. In summary, these researchers propose that gut vagal afferents synapse on the 
nodose ganglion of the vagus nerve, sending signals to brain stem then up to areas of 
midbrain and striatum to facilitate approach and reward behavior (Han et al. 2018). These 
findings are reinforced in a study that found brainstem neurons are activated via gut 
microbial depletion. These neurons can then relay information to premotor glutamatergic 
neurons that feedback to the gut to regulate gut motility (Muller et al. 2020). This reports 
highlights the idea that the gut brain axis is “bi-directional” and that feedback loops exist 
in this circuit involving the brain. Future experiments should refine these and other 
circuits and uncover what are the changes in the brain that occur due to gut dysbiosis. 
Furthermore, are these changes in the brain long lasting and do they impart long term 
detriments to the gut. 
While understanding how the gut and brain communicate is important, 
understanding what changes occur in the brain in response to gut dysbiosis is equally 
vital. Mice that experienced experimenter induced gut microbial depletion were found to 
have an alteration in reward related transcripts in the nucleus accumbens (Kiraly et al. 
2016). It is logical that any change in reward related behavior is not a direct consequence 
of the microbiota, but rather the microbiota acting on the brain which shapes behavior. 
Future experiments should investigate the brain in post-mortem subjects to determine 
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what changes occur in response to gut dysbiosis. Furthermore, examining the brain at 
different stages of antibiotic administration and different phases of cocaine addiction 
(intoxication, withdrawal, and relapse) would uncover exactly how experimenter induced 
gut dysbiosis could affect the brain. Furthermore, examination of brains after probiotic 
treatment would determine if alterations in reward related brain regions return to normal 
when the microbiota returns to normal. 
A major focus of chapter three in this dissertation was to determine the 
reinforcing and punishing qualities of a white noise stimuli. The intensity of the white 
noise used in these experiments was 74-85 dB, which was intended to be aversive, but 
not painful based on previous findings. While this method was effective at facilitating 
acquisition to lever pressing and attenuating cocaine seeking in some animals, it failed to 
influence cocaine taking during self-administration. It is possible that white noise was 
aversive for some subjects and not for others, as there was consider variability in cocaine 
taking behaviors. Future studies should titrate white noise per each animal, with the goal 
of making the noise aversive enough to facilitate lever pressing, but loud enough to 
attenuate cocaine taking and seeking. 
Sampling of the microbiota was done using fecal boli collected from animals at 
various parts of the experiment. This was advantageous to our design as it allowed us to 
assess changes in the microbiota across the experiment. Importantly, baseline samples 
allowed within subject comparisons, a huge advantage since microbiota comparisons to 
control subjects are difficult given that there is no such thing as a standard microbiota. 
The decision to sample the microbiota from fecal samples does have some flaws, the 
biggest of which is loss of several taxa are lost as food moves through the digestive tract 
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to be excreted. Some researchers have suggested that colon or cecal microbiota sampling 
is a better method to assess the microbiota, as key species are not lost through digestion, 
metabolism, or defecation (Stanley et al. 2015;Pang et al. 2012). Combined with findings 
that the microbiota between humans and rodents contains dissimilarities (Nguyen et al. 
2015) consideration for sampling the microbiota in cecum along with running parallel 
experiments using other animal models (such as Mus musculus) are work considering. 
The probiotic administration during abstinence leading to attenuation of cocaine 
seeking during reinstatement is a very promising finding. Unfortunately the power in 
these results is low due to low subject counts in each experimental groups. There are also 
some interesting trends, such as probiotics attenuating reinstatement in adolescent 
animals that are not significant due to high variability and low subject numbers. Follow 
up experiments will bolster the number of subjects in this group to determine if 
behavioral findings hold true or if new findings emerge. Follow-up experiments will also 
need microbiota analysis similar to antibiotic only animals to determine if changes in 
microbiota abundance and diversity relate to changes in cocaine-seeking behavior. We 
are also very interested to test whether probiotics can be used as a prophylactic measure 
to protect against cocaine taking and cocaine-seeking. Future experiments should give 
probiotics to subjects for the duration of the experiment in the hopes that initial cocaine 
use will not be robust. The use of these particular probiotics in specific aim three came 
from previous research that showed attenuation of depression and anxiety like behavior 
through chronic administration in lab rodents (Messaoudi et al. 2011; Arseneault-Breard 
et al. 2012; Ait-Belgnaoui et al. 2014). While this probiotic blend has beneficial effects, 
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future studies should consider targeted probiotic treatment that replace bacteria lost in 
dysbiotic subjects, with the goal to restore the gut microbiota to baseline levels.  
6.3 Final thoughts 
This study examines how the gut microbiota is involved in cocaine-taking and 
cocaine-seeking tasks. An observed variability in cocaine behavior is related to 
microbiota profiles and shifts in cocaine taking are associate with microbiota changes. 
Moreover, microbial depletion is associated with higher cocaine seeking, whereas 
microbial restoration is associated with attenuated cocaine seeking. This study has also 
shown that adolescents are less affected by aversive stimuli than adults, including a 
punishing white noise stimulus as well as gut microbial depletion or restoration. Instead 
of adolescence being thought of as a period of vulnerability, we would like to think of it 
as a period of resiliency during which dynamic changes in brain and gut physiology can 
protect the organism from long-term perturbations. We proposed a vicious cycle of drug 
abuse in which drug seeking behavior can be modulated indirectly via gut-brain axis 
interactions. Maladaptive stimuli can induce gut dysbiosis resulting in modulation of 
reward related brain regions. Altered brain functioning can drive addiction like behaviors 
which perpetuate the cycle. Adolescence is a key period during this cycle as the 
rewarding properties of drugs and the aversive properties of external stimuli are different 
compared to adults. When studying addiction and attempting to create therapies to 
combat substance use disorder, adolescent individuals and the gut brain axis should be 
considered.  
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